SlideShare une entreprise Scribd logo
1  sur  304
HPLC
I/II, Ist Semester M.Pharmacy
Dept . Of Pharmaceutical Analysis, JNTUH
Lecture by:

RAVI PRATAP PULLA

M.Pharm., Ph.D

Asso.Professor, SSJ College of Pharmacy, V.N.Pally,
Gandipet, Hyderabad-75.
SSJCP, Department of Pharmaceutical Analysis

1
HPLC – THE DEVELOPMENT OF A NAME
PERFORMANCE
PRESSURE
Price
Prestige
Peak
Profit
Propaganda
High

Promise

Chromatography

Philosophy
Polite
Problem
Ph (F) antasy

Liquid

Pragmatic
Pleasure
Passion

SSJCP, Department of Pharmaceutical Analysis

2
Introduction to Liquid
Chromatography
Columns
System Components
Applications
Troubleshooting

SSJCP, Department of Pharmaceutical Analysis

3
A Brief History of Chromatography
 1903: Russian botanist Mikhail Tswett separated
plant pigments
 1938: Russian scientists Izmailov and Shraiber use
“drop chromatography”.
 Later perfected as Thin Layer Chromatography
(TLC) by Kirchner in the U.S.
 1952: Martin and Synge receive Nobel Prize for
“invention of partition chromatography” or plate
theory to describe column efficiency.
SSJCP, Department of Pharmaceutical Analysis

4
 1966: HPLC was first named by
Horvath at Yale University but HPLC
didn’t “catch on” until the 1970s
 1978: W.C. Stills introduced “flash
chromatography”, where solvent is
forced through a packed column with
positive pressure.
SSJCP, Department of Pharmaceutical Analysis

5
Modern HPLC
 Late 1970s/early 1980s
►Instrumentation developed for high pressure solvent
delivery: pumps, autosamplers, diode array detectors
► More uniform packing material produced
columns

for

 Last 20 years
► Nothing really “new”, but by returning to the basic
theory of chromatography, even better columns are on the
market: smaller particle sizes which yield faster separations,
but require hardware to withstand higher pressures.
SSJCP, Department of Pharmaceutical Analysis

6
What is Chromatography?
 Separation of a mixture into individual
components.
 The separation uses a Column (stationary phase)
and Solvent (mobile phase).
 The components are separated from each other
based on differences in affinity for the mobile or
stationary phase.
 The goal of the separation is to have the best
RESOLUTION possible between components.
SSJCP, Department of Pharmaceutical Analysis

7
CHROMATOGRAPHY IS
INCOMPLETE WITHOUT
LEARNING
FEW BASIC TERMINOLOGIES
For any further clarification or details of the
below content(s) feel free to mail me :

ravipratappulla@gmail.com
SSJCP, Department of Pharmaceutical Analysis

8
Absorption

Bonded phase

Additive

Breakthrough volume

Adsorbent

Capillary column

Adsorption

Capillary LC

Adsorption isotherm

Cartridge column

Affinity chromatography

Cation exchange chromatography

Agarose

Channeling

Alumina

Chemisorption

Amphoteric ion-exchange phase

Chiral stationary phase

Analyte

Chlorosilane

Anion exchange chromatography

Co-ion

Bed volume

Column back pressure

BET (Brunauer, Emmet & Teller)
Column chromatography
method
SSJCP, Department of Pharmaceutical Analysis
Column plate number

Eluite

Column switching

Elute

Column volume

Elution

Competing base

Exclusion chromatography (Size)

Counterion

Extra column effects

Coverage

Fast protein LC (FPLC)

Cross-links

Frontal chromatography

Dead time (to / tm )
Displacement chromatography

Gel filtration chromatography
(GFC)
Gradient elution

Dynamic coating

Graphitized carbon packing

Effluent

Guard column

Eluate

Heart cutting

Eluent

Hold-up volume ( VM or tM )

Degassing

SSJCP, Department of Pharmaceutical Analysis
Hydrophobic interaction
chromatography (HIC)

Ion exclusion

Ion chromatography

Ion moderated partioning
chromatography (IMPC)

Imprinted phases

Ion pair chromatography (IPC)

Indirect detection

Linear chromatography

Injector (sample)

Linear velocity

Inlet

Liquid chromatography

In-line filter

Mobile phase velocity

Interparticle porosity (ee)

Open tubular column

Interstitial volume

Partition chromatography

Intraparticle porosity (ei)

Packed column

Intraparticle volume

Peak

Ion exchange chromatography

Peak area

Ion chromatography (IC)

Peak maximum

SSJCP, Department of Pharmaceutical Analysis

11
Peak width

Retention factor (k)

Phase ratio

Retention volume (VR or tR)

Plate height (H)

Separation factor (a)

Plate number (N)

Solid support

Pressure drop

Solute

Reduced mobile phase velocity (n) Stationary phase
Resolution (Peak) [ Rs ]/
Resolution(R)

Tailing

Reduced plate height (h)

Void volume

Relative Retention time (RRT)

Retention time (tR )

Interparticle time (tZ)

Capacity factor (k’)

Dead Volume(Vd)
Selectivity factor (α)
SSJCP, Department of Pharmaceutical Analysis

12
Activity

Adsorption chromatography

Asymmetry

Back pressure

Back flushing

Band spacing

Baseline

Baseline noise

Baseline resolved peak

Breakthrough volume

Buffer

Calibration standard

Capacity factor

Chain length

Channeling

Chromatogram

Chromatographic conditions

Chromatographic resolution

Chromatographic system

Column performance

Dead volume (Vm)

Dead time (tm)

Detection

Detector

Detection threshold

Detector linearity

SSJCP, Department of Pharmaceutical Analysis

13
Detector sensitivity

Differential Refractive Index( RI)

Electrochemical detector

Elution order

Elution chromatography

Eluotropic sequence

Elution volume

Extra column volume

External standard

Flow rate

Fluorescence detector

Frit

Fronting

HETP

Hydrophilic

Hydrophobic

Internal standard

Integrator

Interstitial particle volume

Ion exchanger

Ion suppression

Isocratic analysis

Isothermal chromatography

Ligand

Loading

matrix

SSJCP, Department of Pharmaceutical Analysis

14
Organic modifier

Overload

Partially resolved peaks

Particle size (medium)

Particle size distribution

Peak broadening

Peak area

Peak base

Peak height

Peak identification

Peak Quantitation

Peak shape

Phase system

Polarity

Pore diameter

Pore volume

Post column derivatization

Pre column

Pulsating flow

Recycling

Regeneration

Retention

Retention time

Retention volume

Sample

Sample capacity

SSJCP, Department of Pharmaceutical Analysis

15
Sample preparation

Separation capacity

silanization

Silanol groups

Sorbent

S.P chemically bonded

S.P

Surface modification

Specific surface

SFC( supercritical fluid
chromatography)

Vacancy chromatogram

Void

Void time

SSJCP, Department of Pharmaceutical Analysis

16
IUPAC RECOMMENDATIONS &
FREQUENTLY USED SYMBOLS IN
PARAMETER
SYMBOL
CHROMATOGRAPHY α
Separation factor
Selectivity factor (up to 1993 A.D)
Area

α
a/A

Diameter

de

Diffusion coefficient

d
ε / εt

Porosity
Flow rate (volumetric)

f

Plate height

h

Viscosity

η

Equilibrium distribution constant

k

Rate constant

k

Retention factor

k

SSJCP, Department of Pharmaceutical Analysis

17
PARAMETER
Capacity factor

SYMBOL
k’

Length of the column

l / L

Plate number /number of theoretical plates

n / N

Density

ρ

Pressure

p / P

Pressure (relative)

p

Radius

r

Temperature (absolute)
Time

t /T
t

Retention time

tr / tR

Velocity (linear)

u

Volume

v

SSJCP, Department of Pharmaceutical Analysis

18
PARAMETER

SYMBOL

Retention volume

vr

Mass (Weight)

w

Peak width

w

Difference

∆

Partial diameter

dp

Flow

F

Height equivalent of a theoretical plate(HETP)

H

Internal diameter of the column

I.D

Wavelength

λ

Iso electric point

pKa

Resolution

R

Death time

tm / t0

SSJCP, Department of Pharmaceutical Analysis

19
PARAMETER

SYMBOL

Gradient time

tG

Net retention time

tR'

Linear velocity

μ

Dead volume of apparatus

Vd

Pore volume

Vp

For any further clarification or details
of the above content(s) feel free to
mail me :
ravipratappulla@gmail.com
SSJCP, Department of Pharmaceutical Analysis

20
The Most Basic Explanation of
Chromatography Ever

SSJCP, Department of Pharmaceutical Analysis

21
 Drugs in multi component dosage forms,
analyzed by HPLC method because of the several
advantages like:
 Improved resolution of the separated substances
 Faster separation times
 The improved accuracy, precision, & sensitivity
with which the separated substances may be
quantified.
SSJCP, Department of Pharmaceutical Analysis

22
How Do You Get Separation?
 Hardware: pumps, injector, detector
 Column: particle diameter, column
size, packing materials
 Our seminar will focus on the
contribution of each factor to perform
separations.
SSJCP, Department of Pharmaceutical Analysis
23
 Column Considerations
► Theory (including, well...you know)
► Different Stationary Phases
 Hardware Components
► Pumps, Injectors, Detectors, etc.
► Examples of Application-Specific Configurations
 Applications
► Pharmaceuticals and Proteomics
► Food and Beverage, Environmental
► Research and Method Development
SSJCP, Department of Pharmaceutical Analysis

24
 System Troubleshooting
Leaks, Reproducibility, Column Care, and More
 Chromatography Software
Method and Sequence Setup
Calibration Curves and Reporting
 Chromatography Hardware
Modular LC-20 Prominence
Integrated LC-2010HT, Empower 2
SSJCP, Department of Pharmaceutical Analysis

25
Modern HPLC v/s
Traditional LC Methods
 Classical open-column LC.
 Thin-Layer Chromatography (TLC) and
paper chromatography.
 In modern HPLC the columns and packings
are, in general, highly refined, high in
resolving capacity, and are reusable.
SSJCP, Department of Pharmaceutical Analysis

26
HPLC and Pre-HPLC Techniques

SSJCP, Department of Pharmaceutical Analysis

27
MODES OF SEPARATION IN HPLC
 There are different modes of separation in HPLC:
►Normal phase mode
► Reversed phase mode
► RP - Ion pair chromatography
► Affinity/Bioaffinity chromatography
► Size exclusion chromatography
► Displacement chromatography
SSJCP, Department of Pharmaceutical Analysis

28
 Based on mode of chromatography
► Normal phase mode
► Reverse phase mode
 Based on principle of separation
► Adsorption chromatography
► Ion exchange chromatography
► Ion pair chromatography
► Size exclusion chromatography
► Affinity chromatography
SSJCP, Department of Pharmaceutical Analysis

29
 Based on elution technique
► Isocratic separation
► Gradient separation
 Based on the scale of operation
► Analytical HPLC
► Preparative HPLC
 Based on the type of analysis
► Qualitative analysis
► Quantitative analysis
SSJCP, Department of Pharmaceutical Analysis

30
COLUMN TYPES
Normal Phase LC
 Polar - stationary phase: Silica
 Nonpolar - mobile phase: Hexane, Ethyl acetate
 The LEAST polar compound comes out first
 Generally used for separation of non polar
compounds.
SSJCP, Department of Pharmaceutical Analysis

31
Normal Phase HPLC Columns
Cyano

:

`Rugged, moderate polarity,
general use

-OH (Diol)

:

More polar and retentive

Amino

:

Highly polar, less stable

Silica

:

Very rugged, low cost,
adsorbent & Unbonded

NOTE: The cyano column with a low polarity mobile phase (hydrocarbon with
a small amount of another solvent) will act as a normal phase column.

SSJCP, Department of Pharmaceutical Analysis

32
 this method separates analytes based on their affinity for
a polar stationary surface such as silica
 based on analyte ability to engage in polar interactions
(such as hydrogen-bonding or dipole-dipole type of
interactions) with the sorbent surface.
 Adsorption strengths increase with increased analyte
polarity
 interaction strength depends on the functional groups
present in the structure of the analyte molecule, but also
on steric factors
SSJCP, Department of Pharmaceutical Analysis

33
 more polar solvents in the mobile phase will decrease
the retention time of analytes
 hydrophobic solvents tend to induce slower elution
(increased retention times)
 traces of water in the mobile phase tend to adsorb to the
solid surface of the stationary phase forming a stationary
bound (water) layer which is considered to play an active
role in retention. 
 governed
mechanism

almost

exclusively

by

an

SSJCP, Department of Pharmaceutical Analysis

adsorptive

34
Reversed-Phase LC
 Nonpolar - stationary phase: C8, C18
 Polar - mobile phase: Water, ACN, Methanol
 The MOST polar compound comes out first
 Generally used for separation of polar compounds

SSJCP, Department of Pharmaceutical Analysis

35
C18, C8

RP-HPLC Columns

:

Rugged, general purpose, highly retentive

C3, C4

:

Less retentive, used mostly for peptides &
proteins

Phenyl

:

Greater selectivity than alkyl-bonded

Cyano

:

Moderate retention, normal & rev. phase

Amino

:

Weak retention, good for carbohydrates

NOTE

:

The cyano column with a high polarity mobile phase
(Water/MeOH) will act as a RP- Column.

SSJCP, Department of Pharmaceutical Analysis

36
 stationary phase is a silica which has been surfacemodified with RMe2SiCl, where R is a straight chain alkyl
group such as C18H37 or C8H17.
 retention time is longer for molecules which are less
polar, while polar molecules elute more readily 
 can increase retention times by adding more water to
the mobile phase
 the affinity of the hydrophobic analyte for the
hydrophobic stationary phase stronger relative to the now
more hydrophilic mobile phase
SSJCP, Department of Pharmaceutical Analysis

37
 decrease retention time by adding more organic solvent
to the eluent
 RP-HPLC operates on the principle of hydrophobic
interactions
 RP-HPLC allows the measurement of these interactive
forces. 
 The binding of the analyte to the stationary phase is
proportional to the contact surface area around the nonpolar segment of the analyte molecule upon association
with the ligand on the stationary phase.
SSJCP, Department of Pharmaceutical Analysis

38
 solvophobic effect is dominated by the force of water for

"cavity-reduction" around the analyte and the C18-chain versus
the complex of both.
 The retention can be decreased by adding a less polar solvent

(methanol, acetonitrile) into the mobile phase to reduce the
surface tension of water. 
 Gradient elution uses this effect by automatically reducing

the polarity and the surface tension of the aqueous mobile
phase during the course of the analysis.
 Structural properties of the analyte molecule play an

important role in its retention characteristics.
SSJCP, Department of Pharmaceutical Analysis

39
 an analyte with a larger hydrophobic surface area (C-H,
C-C, and generally non-polar atomic bonds, such as S-S and
others) is retained longer because it is non-interacting with
the water structure.
 analytes with higher polar surface area (conferred by the
presence of polar groups, such as -OH, -NH2, COO– or
-NH3+ in their structure) are less retained as they are better
integrated into water.
 interactions are subject to steric effects in that very large
molecules may have only restricted access to the pores of
the stationary phase, where the interactions with surface
ligands (alkyl chains) take place.
SSJCP, Department of Pharmaceutical Analysis

40
 surface hindrance typically results in less retention.
 Retention time increases with hydrophobic (non-polar)
surface area.
 Branched chain compounds elute more rapidly than
their corresponding linear isomers because the overall
surface area is decreased.
 organic compounds with single C-C-bonds elute later
than those with a C=C or C-C-triple bond, as the double or
triple bond is shorter than a single C-C-bond.
SSJCP, Department of Pharmaceutical Analysis

41
 mobile phase surface tension (organizational strength
in eluent structure), other mobile phase modifiers can
affect analyte retention.
 entropy of the analyte-solvent interface is controlled
by surface tension, the addition of salts tend to increase
the retention time.
 mobile phase pH can change the hydrophobic
character of the analyte.
 For this reason most methods use a buffering agent,
such as sodium phosphate, to control the pH. 
SSJCP, Department of Pharmaceutical Analysis

42
 Ammonium formate is commonly added in mass
spectrometry to improve detection of certain analytes by
the formation of analyte-ammonium adducts.
 volatile organic acid such as acetic acid, or formic acid,
is often added to the mobile phase if mass spectrometry is
used to analyze the column effluent.
 Trifluoroacetic acid is used infrequently in mass
spectrometry applications due to its persistence in the
detector and solvent delivery system, but can be effective
in improving retention of analytes such as carboxylic
acids in applications utilizing other detectors, as it is a
fairly strong organic acid. 
SSJCP, Department of Pharmaceutical Analysis

43
 Reversed phase columns consist of alkyl derivatized silica

particles and should never be used with aqueous bases as
these will destroy the underlying silica particle.
 Can be used with aqueous acid, but the column should not

be exposed to the acid for too long, as it can corrode the
metal parts of the HPLC equipment.
 A good test for the metal content of a column is to inject a

sample which is a mixture of 2,2'- and 4,4'- bipyridine.
 Because the 2,2'-bipy can chelate the metal, the shape of

the peak for the 2,2'-bipy will be distorted (tailed)
when metal ions are present on the surface of the silica.
SSJCP, Department of Pharmaceutical Analysis

44
TYPICAL COLUMN SIZES

SSJCP, Department of Pharmaceutical Analysis

45
SSJCP, Department of Pharmaceutical Analysis

46
 Particle size: 5 µm, 3 µm, and smaller
 Mono dispersed means particles are the same size
 Very important for stable pressure and flow
 Smaller particles produce higher system pressure
► Pore size: 100-120 A is typical
► Surface area: 300-350 m2/g
► Carbon load: 9-12% for C8, 16-20% for C18
 Higher carbon load = better resolution but longer run times
 Lower carbon load = shorter run times, but may change selectivity
v/s higher carbon load
SSJCP, Department of Pharmaceutical Analysis

47
RP-HPLC MECHANISM






Synthesis of RP Packing
RP Column Properties
RP Retention Mechanisms
Important RP parameters
RP Optimization

SSJCP, Department of Pharmaceutical Analysis

48
Synthesis of RP Packing

SSJCP, Department of Pharmaceutical Analysis

49
RP COLUMN PREPARATION

SSJCP, Department of Pharmaceutical Analysis

50
COMMON RP PACKING

SSJCP, Department of Pharmaceutical Analysis

51
RP COLUMN PROPERTIES
► Hydrophobic Surface
► Particle Size and Shape
► Particle Size Distribution
► Porosity, Pore Size and Surface Area
SSJCP, Department of Pharmaceutical Analysis

52
PARTICLE SIZE
► Columns have a distribution of particle sizes

► Reported “particle diameter” is an average

► Broader distribution ---> broader peaks
SSJCP, Department of Pharmaceutical Analysis

53
Particle Size
Distribution of several column batches

Copyrights: Neue, HPLC Columns Theory, Technology and Practice, Wiley, 1997, p.82

SSJCP, Department of Pharmaceutical Analysis

54
RP MECHANISM (SIMPLE)

SSJCP, Department of Pharmaceutical Analysis

55
RP Mechanism (Advanced)
 Classical measures of retention
► capacity factors
► partition coefficients
► Van’t Hoff Plots
 Give bulk properties only
► do not give molecular view of
separation process
SSJCP, Department of Pharmaceutical Analysis

56
PROPOSED RP MECHANISMS
► Hydrophobic Theory
► Partition Theory
► Adsorption Theory
SSJCP, Department of Pharmaceutical Analysis

57
HYDROPHOBIC THEORY
 Chromatography of “cavities” in solvent created
by hydrophobic portion of analyte molecule
 Surface Tension
 Interaction of polar functions with solvent
 Stationary phase is passive
SSJCP, Department of Pharmaceutical Analysis

58
PARTITION THEORY
 Analyte distributes between aqueous mobile
phase and organic stationary phase
 Correlation between log P and retention
“organic” phase is attached on one end
 Does not explain shape selectivity effects
SSJCP, Department of Pharmaceutical Analysis

59
ADSORPTION THEORY
 Analytes “land” on surface - do not penetrate
 Non-polar interactions between analyte hydrophobic
portion and bonded phase
 Weak interactions
► dipole-dipole
► dipole-induced dipole
► induced dipole-induced dipole
SSJCP, Department of Pharmaceutical Analysis

60
None of the above can completely
explain all of the observed
retention in RP-HPLC

SSJCP, Department of Pharmaceutical Analysis

61
IMPORTANT REVERSED PHASE PARAMETERS

 Solvent (mobile phase ) Strength
 Choice of Solvent
 Mobile Phase pH
 Silanol Activity
SSJCP, Department of Pharmaceutical Analysis

62
SOLVENT STRENGTH
 Water is “weak” solvent
 Increased organic ---> decreased
retention
 Organic must be miscible with water
SSJCP, Department of Pharmaceutical Analysis

63
EFFECT OF SOLVENT

SSJCP, Department of Pharmaceutical Analysis

64
SOLVENT STRENGTH

COPYRIGHTS:Snyder and Kirkland, Introduction to Modern Liquid Chromatography, Wiley, 1979, p. 286.

SSJCP, Department of Pharmaceutical Analysis

65
VARYING SELECTIVITY
30% MeCN

45% MeOH

70% Water

55% Water

30x0.46 cm C-18, 1.5
mL.min,254 nm, 10 mg each

COPYRIGHTS:Snyder and
Kirkland, introduction to
Modern Liquid
Chromatography, Wiley,
1979, p. 287.

SSJCP, Department of Pharmaceutical Analysis

66
pH
 Affects ionizable compounds
► organic acids
► organic bases
 In reversed phase we need to suppress ionization
as much as possible
 May need very precise pH control
SSJCP, Department of Pharmaceutical Analysis

67
pH Effect on Retention
1. Salicylic acid
2. Phenobarbitone
3. Phenacetin
4. Nicotine
5. Methylampohetamine
30x0.4 cm C-18, 10 mm, 2
mL/min, UV 220 nm
COPYRIGHTS: Snyder and Kirkland,
Introduction to Modern Liquid Chromatography,
Wiley, 1979, p. 288.

SSJCP, Department of Pharmaceutical Analysis

68
Use of Buffers
 0.1 pH unit ---> significant effect on retention
 Buffer mobile phase for pH reproducibility
 pH of buffer should be within 1 pH unit of pKa of acid (best
at pH = pKa)
 Buffers weak (100 mM or less)
 Check solubility
SSJCP, Department of Pharmaceutical Analysis

69
Common buffers
Buffer

pKa Values

Phosphate

2, 7

Acetate

4.75

Citrate

3.08, 4.77, 6.40

Useful buffering between pH 2-8.

SSJCP, Department of Pharmaceutical Analysis

70
Silanol Activity
 RP ligands occupy about 50% of
silanols
 Others are “active”
 Weak acids
SSJCP, Department of Pharmaceutical Analysis

71
Silica Surface

SSJCP, Department of Pharmaceutical Analysis

72
Dealing with Residual Silanols
 Silanols cause peak tailing and excessive retention
 Endcapping
► bond a smaller group (helps a little)
 Pre-treatment of silica
► fully hydroxylated best
► high purity best
SSJCP, Department of Pharmaceutical Analysis

73
Silanol Interactions
 Hydrogen bonding
 Dipole-dipole
 Ion exchange
 Low pH --> silanols protonated
 Add basic modifier (TEA) to compete for sties
SSJCP, Department of Pharmaceutical Analysis

74
pH Effect on Tailing

Neue, p196

SSJCP, Department of Pharmaceutical Analysis
RP Optimization

SSJCP, Department of Pharmaceutical Analysis

76
SSJCP, Department of Pharmaceutical Analysis

77
IDEALIZED HPLC SEPARATION

SSJCP, Department of Pharmaceutical Analysis

78
VOID VOLUME
 The void volume is the amount of “dead” volume
in the column that is not taken up by the particles
of stationary phase.
 In general, there is approximately 0.1 mL of void
volume for each cm of column length, for columns
with a 4.6 mm i.d. and 5 µm particles

Vm ≈ 0.5dc2L
Where,

Vm is the column volume in mL,
L is the column length in cm, and
dc is the inner diameter in cm

SSJCP, Department of Pharmaceutical Analysis

79
 The void volume is exactly determined by
injecting a compound that is completely
unretained, then using the chromatogram to
calculate void volume.
 void volume = Elution time x flow rate

SSJCP, Department of Pharmaceutical Analysis

80
FACTORS INFLUENCING
RESOLUTION
 Capacity Factor, k’
 Selectivity Factor, α
 Efficiency, N

SSJCP, Department of Pharmaceutical Analysis

81
RESOLUTION
 For closely eluting or adjacent peaks, the
resolution equation may be expressed as:

Rs = 1 / 4[(α − 1) / α ] N [k ' /(1 + k ' )]
 The terms of capacity factor (k’), selectivity (α),
and efficiency (N) all contribute to resolution
SSJCP, Department of Pharmaceutical Analysis

82
THE RESOLUTION
EQUATION
 Resolution is defined as the completeness of
separation from one analyte to another
 In general, resolution may be expressed as:
Rs

= 2(Vrb - Vra)/(Wa + Wb)
= 2(trb - tra)/ (Wa + Wb)

Where,
Vra/b = retention volume of peak a/b
t a/b = retention time of peak a/b
SSJCP, rDepartment of Pharmaceutical Analysis

83
CAPACITY FACTOR, k

’

 The relative degree to which an analyte component is
delayed as it is eluted through a given system (retentivity).
k’ = (V r - V 0 )/V 0

=

(t r - t 0 )/t 0

Where,
Vr = peak retention volume
V0 = column void volume
tr = peak retention time
t0 = peak void time

 The larger the k’, the later the analyte elutes after the
void.
SSJCP, Department of Pharmaceutical Analysis

84
EFFECT OF k’ ON OVERALL RESOLUTION
 As k’ grows larger, its effect reaches a limit at a value of
about 10.
 Since k’ depends on retention time, longer columns
eventually have a diminished effect on resolution.

SSJCP, Department of Pharmaceutical Analysis

85
INFLUENCING THE CAPACITY FACTOR (k’)
 Retentivity (k’) decreases 2 - 3 fold for each 10% increase in mobile phase
strength.
 Which of these is easiest to change??
► Mobile Phase Strength As per the rule of thumb, altering the mobile phase strength also
alters the retention of the analytes.
► Bonded Phase Functionality (RP) As the bonded phase hydrophobicity increases (increasing alkyl
chain length, etc.) so will the retention of the analytes.
► Temperature As temperature increases, the retention time decreases. This does
not necessarily result in poorer separation because of the other
factors in the resolution equation.

SSJCP, Department of Pharmaceutical Analysis

86
Mobile Phase Strength v/s k
4.6 mm ID Column, 1 mL/min,
Changing MeOH % vs Water

0.079
100%
100%

90%
90%

’

Capacity Factor for Butyl Paraben (Peak 4)

0.212

0.472
80%
80%

70%
70%

1.127
2.813

60%
60%

7.666

50%
50%

SSJCP, Department of Pharmaceutical Analysis

87
Temperature Effect on k
50°C

’

2.1 mm ID Column, 0.35 mL/min, 50/50
MeOH/Water

45°C

40°C

35°C

30°C

25°C

20°C

SSJCP, Department of Pharmaceutical Analysis

88
Summary of k Effects
’

 A larger value of k’ means better resolution...to a
certain extent (k’ = 10 maximum)
 Increasing the mobile phase strength decreases k’
 Increasing the temperature decreases k’, but may
not result in a “bad” separation based on the other
factors affecting resolution.
SSJCP, Department of Pharmaceutical Analysis

89
Selectivity Factor, α

 The selectivity or separation factor represents the ratio of any two

adjacent k’ values, there by describing the relative separation of adjacent
peaks.

 This relationship is expressed as:
α = k’b/k’a

 If α = 1, two components are perfectly overlapping
 For early eluting peaks you want α to be large for good resolution.
 For later eluting peaks, α can be smaller and still have acceptable
separation.

SSJCP, Department of Pharmaceutical Analysis

90
Effect of α on Overall Resolution

 Remember the resolution equation?

Rs = 1 / 4[(α − 1) / α ] N [k ' /(1 + k ' )]
 Let’s only look at the part involving α

Rs = 1 / 4[(α −1) / α]

 And see how much resolution will improve with small changes in α

SSJCP, Department of Pharmaceutical Analysis

91
 For an α value of 1.1, the contribution of the
selectivity term is
(1.1 – 1) / 1.1 = 0.09
 For an α value of 1.4, the contribution of the
selectivity term is
(1.4 – 1) / 1.4 = 0.29
 So, a very small change in α leads to a more than
THREE-FOLD increase in the contribution to
resolution.
SSJCP, Department of Pharmaceutical Analysis

92
 As α grows larger, its effect reaches a limit at a value of about
5.
 Since α depends on components’ retention factor k’, longer
columns eventually have a diminished effect on resolution.

SSJCP, Department of Pharmaceutical Analysis

93
Influencing the Selectivity Factor α
 Which of these is easiest to change??
► Mobile Phase Type The importance of the type of interactions between
the
mobile phase and analytes is critical to the
optimization of the selectivity of a system.
► Column Type The bonded phase functionality can be selected by its
chemical nature to provide better selectivity in an
analytical method.
► Temperature Selective interactions between analyte molecules and
the stationary phase may not become evident until a
critical temperature is attained.
SSJCP, Department of Pharmaceutical Analysis

94
Summary of α Effects
 Since α is the ratio of two k’ values, the same general
statements apply:
►

Increasing the mobile phase strength decreases
individual
values of k’, but their ratio (α) may affect
resolution
► Increasing the temperature decreases individual values of

k’, but their ratio (α) may significantly affect resolution.

 A small increase in α leads to a large increase in resolution
SSJCP, Department of Pharmaceutical Analysis

95
Column Efficiency, N
 The column efficiency is defined as the degree to which
a column and/or other system components can physically
and chemically affect the separation of analytes.
 As column efficiency increases, analyte components will
elute in a smaller volume of the mobile phase, usually
observed as narrower or “sharper” peak shapes.
 Column efficiency is generally expressed in terms of
theoretical plate number.

SSJCP, Department of Pharmaceutical Analysis

96
Calculation of Theoretical Plates

N = A(tr /W)2
W

A
4

Wh

5.54

Wi

Method
Width measured at
Inflection point (60.7% of peak height)
½ Height

50% of peak height

W3s

3s

32.4% of peak height

W4s

16

4s

13.4% of peak height

W5s 25
Wb

9

5s

4.4% of peak height

16

Tangent Baseline, following tangent drawing

Constants A are different at each peak width, assuming a perfect Gaussian shape.
Real-world peaks often have tailing, so widths measured at the lower part of the peak more accurately reflect the
tailing when calculating N.

SSJCP, Department of Pharmaceutical Analysis

97
Calculation of Efficiency, N

Width measured at the
baseline after tangent
lines are drawn on the
peak.
Used when
tailing is minimal.

Width measured at
4.4% of peak height,
no tangents drawn.
Used when tailing is
significant.

SSJCP, Department of Pharmaceutical Analysis

98
Effect of N on Overall Resolution
 Do you STILL remember the resolution equation?

Rs let’s/lookαat − 1)part ]involving/(1 + k ' )]
= 1 4[( the / α N [k ' N
 Now
Rs = 1 / 4 N

 And see how much resolution will improve with
changes in N

SSJCP, Department of Pharmaceutical Analysis

99
 Since the contribution of N to resolution is a
square root, doubling N from 5000 to 10,000 only
increases the contribution to resolution by 41%.
 To double the effect on resolution coming from
N, we have to increase the value of N by a factor of 4
PLATE

Plates
5000
5,000
10,000
10,000
20,000
20,000

√N

CONTRIBUTION

141.4

100%

√N
Contribution
70.7 70.7
- - - - ----100 100
41% 41%
141.4
100%

SSJCP, Department of Pharmaceutical Analysis

100
Effect of N on Overall Resolution

 Note that there is no flattening of the curve like with k ’ and α.
 Resolution will continue to increase as theoretical plates increase.
SSJCP, Department of Pharmaceutical Analysis

101
Influencing the Efficiency, N
 Particle Size and Size Distribution The smaller the particle size and the narrower the range of the
particle size distribution, the more efficient the column.

 Packing Type Totally porous particles will also have greater efficiency than
solid or pellicular-shaped packing's, due to the additional
surface area attributable to the pores.

 Mobile Phase Viscosity As mobile phase viscosity increases, molecular movement
through the mobile phase is inhibited.

 Temperature For reverse phase chromatography, an increase in efficiency, N,
may be realized as column temperature is increased.
SSJCP, Department of Pharmaceutical Analysis

102
Effect of Particle Size on N
 Smaller particle sizes result in higher numbers of theoretical plates
Column
Diameter (mm)

Column Length
(cm)

Particle Size
(µm)

4σ Peak
Width (µL)

Theoretical Plates per
centimeter

10

25

10

1118

333

4.6

25

10

237

333

4.6

25

5

167

667

4.6

10

5

106

667

4.6

10

3

82

1111

4.6

3

3

45

1111

3

10

5

45

667

2

25

10

45

333

2

25

5

32

667

2

10

5

20

667

2

10

3

15

1111

1

25

10

11

333

1

25

5

8

667

1

25

3

6

1111

1

10

5

5

667

1

10

3

4

1111

SSJCP, Department of Pharmaceutical Analysis

103
Relative Influence of All Factors on Resolution
Parameter
Change

N

k’

α

Rs

Standard
+10% N
-25% N
-50% N
-60% N
-75% N
+10% k’
+10% α

10,000
11,000
7,500
5,000
4,000
2,500
10,000
10,000

2
2
2
2
2
2
2.2
2

1.1
1.1
1.1
1.1
1.1
1.1
1.1
1.2

1.52
1.59
1.31
1.07
0.96
0.76
1.56
2.78

Note that changing α a very small amount has the biggest effect

SSJCP, Department of Pharmaceutical Analysis

104
Review of Factors

PARAMTER

INFLUENCED BY

TARGET VALUE

Efficiency, N

Column, system
flow path,
configuration

Minimum of 400
theoretical
plates /cm

Capacity factor,
k’

MP strength

1.0 - 10

Selectivity, α

M.P & S.P type

1.1 - 2

All of the above

1.3 – 1.5 or
greater

Resolution, Rs

SSJCP, Department of Pharmaceutical Analysis

105
Normal Phase v/s Reversed Phase
PARAMETER

NP

RP

Polarity of
packing

Medium to high

Low to medium

Polarity of
solvent

Low to medium

Medium to high

Elution sequence Low polarity first High polarity first
Increase solvent
polarity

Faster elution

Slower elution

SSJCP, Department of Pharmaceutical Analysis

106
ION EXCHANGE CHROMATOGRAPHY

SSJCP, Department of Pharmaceutical Analysis

107
 based on the attraction between solute ions and charged sites
bound to the stationary phase.
 The stationary phase contains ionic groups like NR⁺з, SO⁻з which
interact with the ionic groups of the sample molecules.
 This method is suitable for the separation of charged molecules
only.
 Solute ions of the same charge as the charged sites on the column
are excluded from binding
 solute ions of the opposite charge of the charged sites of the
column are retained on the column.
 Strong acids & basic compounds may be separated by RP mode by
forming ion pairs with suitable counter ions.
SSJCP, Department of Pharmaceutical Analysis

108
 Solute ions that are retained on the column can be
eluted from the column by changing the solvent conditions
 They include:
► increasing the ion effect of the solvent system
► by increasing the salt concentration of the
solution
► increasing the column temperature
► changing the pH of the solvent 

SSJCP, Department of Pharmaceutical Analysis

109
 ion exchangers favor the binding of ions of higher charge
and smaller radius.
 increase in counter ion (with respect to the functional
groups in resins) concentration reduces the retention time.
 decrease in pH reduces the retention time in cation
exchange while an increase in pH reduces the retention time
in anion exchange. 
 lowering the pH of the solvent in a cation exchange
column, more hydrogen ions are available to compete for
positions on the anionic stationary phase, thereby eluting
weakly bound cations.
SSJCP, Department of Pharmaceutical Analysis

110
TYPES OF ION EXCHANGERS
 Polystyrene resins
►These allow cross linkage which increases the
stability of the chain.
►Higher cross linkage reduces swerving,
which increases the equilibration time and
ultimately improves selectivity.
 Cellulose and dextran ion exchangers (gels)
► These possess larger pore sizes and low charge
densities making them suitable for protein
separation.
 Controlled-pore glass or porous silica
SSJCP, Department of Pharmaceutical Analysis

111
Examples
 Stationary phase contains charged groups
 SAX (Strong Anion Exchange): NH3+
 WAX (Weak Anion Exchange): NR2H+(DEAE)
[Di Ethyl Amino Ethanol]
 SCX (Strong Cation Exchange): SO3-

 WCX (Weak Cation Exchange): CarboxyMethyl
(CM)
 More highly charged analytes have stronger
retention
 More “bulky” stationary phases have weaker
retention
SSJCP, Department of Pharmaceutical Analysis

112
 IEC is widely used in the following applications:
►water purification
► preconcentration of trace components
► ligand-exchange chromatography
► ion-exchange chromatography of proteins
► high-pH anion-exchange chromatography
of carbohydrates and oligosaccharides
SSJCP, Department of Pharmaceutical Analysis

113
AFFINITY/ BIOAFFINITY CHROMATOGRAPHY

SSJCP, Department of Pharmaceutical Analysis

114
AFFINITY CHROMATOGRAPHY
 It uses highly specific biochemical interactions
for separations.
 The stationary phase contains specific groups
of molecules which can absorb the sample if
certain steric & charge related conditions are
satisfied.
 This technique can be used to isolate proteins,
enzymes, receptors , ligands as well as
antibodies from complex mixture.
SSJCP, Department of Pharmaceutical Analysis

115
Affinity chromatography can be used to:
 Purify and concentrate a substance from a
mixture into a buffering solution
 Reduce the amount of a substance in a mixture
 Discern what biological compounds bind to a
particular substance
 Purify and concentrate an enzyme solution.
SSJCP, Department of Pharmaceutical Analysis

116
Size Exclusion LC (or) Gel Permeation (or) Gel
filtration

SSJCP, Department of Pharmaceutical Analysis

117
 Stationary phase is a polymer (polystyrene-divinyl benzene or acrylamide) with
a defined pore size
 Large compounds cannot fit into the pores and elute first
 Used to determine molecular weight distribution of polymers
 Separates molecules according to their molecular mass.
 Largest molecules are eluted first and smaller molecules last.
 useful for determining the tertiary structure andquaternary structure of
purified proteins.
 used primarily for the analysis of large molecules such as proteins or polymers.
 SEC works by trapping these smaller molecules in the pores of a particle. 
 widely used for the molecular weight determination of polysaccharides.

SSJCP, Department of Pharmaceutical Analysis

118
 larger molecules simply pass by the pores as they are too large to
enter the pores.
 Larger molecules therefore flow through the column quicker than
smaller molecules, that is, the smaller the molecule, the longer the
retention time.
 separates particles on the basis of molecular size (actually by a
particle's Stokes radius or Stokes-Einstein radius, or hydrodynamic
radius (RH).
 named after George Gabriel Stokes is the radius of a hard sphere
that diffuses at the same rate as the molecule.
 generally a low resolution chromatography and thus it is often
reserved for the final, "polishing" step of the purification.
SSJCP, Department of Pharmaceutical Analysis
 The main application of gel-filtration chromatography:
► fractionation of proteins and other water-soluble
polymers
► while gel permeation chromatography is used to
analyze the molecular weight distribution of organicsoluble polymers.
► Either technique should not be confused with gel
electrophoresis, where an electric field is used to "pull" or
"push" molecules through the gel depending on their
electrical charges.
SSJCP, Department of Pharmaceutical Analysis

120
DISPLACEMENT CHROMATOGRAPHY
 A molecule with a high affinity for the chromatography
matrix (the displacer) will compete effectively for binding sites,
and thus displace all molecules with lesser affinities
 displacement chromatography has advantages over elution
chromatography in that components are resolved into
consecutive zones of pure substances rather than “peaks”. 
 because the process takes advantage of the nonlinearity of
the isotherms, a larger column feed can be separated on a given
column with the purified components recovered at
significantly higher concentration.
SSJCP, Department of Pharmaceutical Analysis

121
Aqueous Normal-Phase Chromatography
(ANP)
 ANP is a chromatographic technique which
encompasses the mobile phase region between RPC
and organic normal phase chromatography
(ONPC).
 This technique is used to achieve unique
selectivity for hydrophilic compounds, showing
normal phase elution using reversed-phase
solvents.
SSJCP, Department of Pharmaceutical Analysis

122
ISOCRATIC & GRADIENT ELUTION
 A separation in which the mobile phase composition remains
constant throughout the procedure is termed isocratic (constant
composition).
 Word was coined by Csaba Horvath
 A separation in which the mobile phase composition is changed
during the separation process is described as a gradient elution
 In isocratic elution, peak width increases with retention time
linearly 
 leads to the disadvantage that late-eluting peaks get very flat and
broad. 
SSJCP, Department of Pharmaceutical Analysis

123
 Gradient elution decreases the retention of the latereluting components so that they elute faster, giving
narrower (and taller) peaks for most components
 improves the peak shape for tailed peaks, as the
increasing concentration of the organic eluent pushes the
tailing part of a peak forward.
 increases the peak height (the peak looks "sharper")
 may include sudden "step" increases in the percentage
of the organic component, or different slopes at different
times.
SSJCP, Department of Pharmaceutical Analysis

124
 In isocratic elution, the selectivity does not change if the
column dimensions (length and inner diameter) change
 In gradient elution, the elution order may change as the
dimensions or flow rate change
 The driving force in RPC originates in the high order of
the water structure.
 The role of the organic component of the mobile phase is to
reduce this high order and thus reduce the retarding strength
of the aqueous component.
SSJCP, Department of Pharmaceutical Analysis

125
ISOCRATIC SYSTEM
 Same mobile phase concentration throughout
the separation
 Use 1 pump and pre-mix solvents
 Use 1 pump and a valve for 4 different solvents
 Use 2 pumps and vary the amount coming from
each pump
SSJCP, Department of Pharmaceutical Analysis

126
ISOCRATIC SEPARATION
 1 pump and premixing
 4.6 mm ID Column, 1 mL/min, Changing MeOH % vs
Water

SSJCP, Department of Pharmaceutical Analysis

127
 1 pump with valve and premixing

To Column
To Column

A = 80% Methanol, 20% Water
B = 70% Methanol, 30% Water
ABCD

C = 60% Methanol, 40% Water
D = 50% Methanol, 50% Water

SSJCP, Department of Pharmaceutical Analysis

128
 1 pump with mixer – let the pump do the work!

To Column
To Column

Method 1: A.CONC = 20%, B.CONC = 80%
Method 2: A.CONC = 30%, B.CONC = 70%
Method 3: A.CONC = 40%, B.CONC = 60%
ABCD

Method 4: A.CONC = 50%, B.CONC = 50%

SSJCP, Department of Pharmaceutical Analysis

129
LOW PRESSURE GRADIENT
1 Pump, solvents are mixed before the pump
Requires degassing
To Column
To Column

ABCD

SSJCP, Department of Pharmaceutical Analysis

130
HIGH PRESSURE GRADIENT
Binary Gradient
2 Pumps and Mixer

Ternary Gradient
3 Pumps and Mixer
……….
……….
……….

……….
……….
……….

……….
……….
……….

SSJCP, Department of Pharmaceutical Analysis

131
HIGH v/s LOW PRESSURE GRADIENT
 High Pressure Gradient
► Multiple pumps are used with a mixer after the
pumps

 Low Pressure Gradient
► Solvents are mixed before the pump

SSJCP, Department of Pharmaceutical Analysis

132
Gradient v/s Isocratic Conditions: Summarized
 Isocratic
► mobile phase solvent composition remains constant with
time
► Best for simple separations
► Often used in quality control applications that support
and
are in close proximity to a manufacturing process
 Gradient
► mobile phase solvent (“B”) composition increases with
time
► Best for the analysis of complex samples
► Often used in method development for unknown mixtures
► Linear gradients are most popular (for example, the
“gradient” shown at right)
SSJCP, Department of Pharmaceutical Analysis

133
PRINCIPLE OF SEPARATION


The principle of separation is Adsorption.

 Separation of components takes
place
because of the difference
in affinity of
compounds towards stationary phase.
SSJCP, Department of Pharmaceutical Analysis

134
The principle of separation in normal phase mode and reverse
phase mode is adsorption.
 The component which has more affinity towards the adsorbent,
travels slower.
 The component which has less affinity towards the stationary
phase travels faster.
 Since no two components have the same affinity towards the
stationary phase, the components are separated.
1
Stronger
interaction

2

Weaker
interaction

SSJCP, Department of Pharmaceutical Analysis

135
PRESENT CHALLENGES
 Analysis of matrices like pharmaceutical dosage forms and
biological samples will always be challenging, due to their great
diversity, intricacy and complexity.
 Analyzing complex samples like biological products and
biological fluids is a significant challenge even with today’s
advanced and sophisticated instrumentation.
 Quality assurance & quality control of pharmaceuticals and
formulations play a vital role in ensuring the availability of safe
& effective drug products to the population.
 Quantitative estimation of the chemical entity of a drug
substance is pivotal to its quality assurance and control.
SSJCP, Department of Pharmaceutical Analysis

136
 The problem may be a simple one when one is dealing with a
pure and single substance.
 But, during the process of formulation, the original drug
substance of high purity is often diluted and mixed with other
additives.
 This may lead to interferences of the additives in the method of
estimation.
 The overall aim of our research is to develop new methods for
quantitative determination of novel drugs in pharmaceutical
dosage forms.
 The emphasis is to find new principles for separations using
liquid chromatography (HPLC) and to understand the mechanisms
behind.

SSJCP, Department of Pharmaceutical Analysis

137
INSTRUMENTATION

SSJCP, Department of Pharmaceutical Analysis

138
SCHEMATIC REPRESENTATION OF AN HPLC UNIT
1.Solvent reservoirs 2. Solvent degasser 3. Gradient valve
4. Mixing vessel for delivery of the mobile phase 5. Highpressure pump 6.Switching valve in "inject position” &
Switching valve in "load position” 7. Sample injection loop
8.Pre-column(guard column) 9. Analytical column 10. Detector
(i.e. IR, UV) 11. Data acquisition 12. Waste or fraction collector

SSJCP, Department of Pharmaceutical Analysis

139
BASIC FLOW CHART OF A HPLC SYSTEM SETUP

SSJCP, Department of Pharmaceutical Analysis

140
HPLC System Components
 Pumps

► Micro to Analytical to Preparative Flow Rates
► Isocratic and Gradient Configurations
 Degasser

► How it Affects Pumping and Sample Injection
 Valves

► Solvent Selection and Flow Selection
SSJCP, Department of Pharmaceutical Analysis

141
 Sample Injection
► Manual Injector or Autosampler
 Oven
► How Temperature Affects Separation
► Valves for Column Switching
 Detectors
► UV-VIS
► Diode Array
► Fluorescence
► Light Scattering
► Refractive Index
► Conductivity
► Mass Spectrometer
 Recorders and Integrators
SSJCP, Department of Pharmaceutical Analysis

142
 Fraction Collector
► Isolate Specific Sample Components
► Purify Compounds for Multi-Step
Synthesis
 Column
► Types of Packing Material
► Factors Affecting Separation
► Particle Size and Column Length
► Flow Rate and Temperature
SSJCP, Department of Pharmaceutical Analysis

143
A SOLVENT DELIVERY SYSTEM
 A mobile phase is pumped under pressure from one
or several reservoir and flows through the column at a
constant rate.
 For NP separation eluting power increases with
increasing polarity of the solvent but for reversed
phase separation, eluting power decreases with
increasing polarity.
 A degasser is needed to remove dissolved air and
other gases from the solvent.
SSJCP, Department of Pharmaceutical Analysis

144
HPLC DEGASSING
 Degassing removes dissolved air that interferes with check valve operation
 Refluxing
► not practicable
 Ultrasonic degassing
► ineffective & applicable for ACN/ Water
 Helium sparge
► Gas line from the tank directly in the solvent bottle
 Vacuum degassing
► Sonicate before connecting to the system
► Online with a degassing unit

SSJCP, Department of Pharmaceutical Analysis

145
Various solvent delivery systems

SSJCP, Department of Pharmaceutical Analysis

146
PUMP MODULES
Types:
 Isocratic pump
► delivers constant mobile phase composition;
► solvent must be pre-mixed;
► lowest cost pump
 Gradient pump
► delivers variable mobile phase composition;
► can be used to mix and deliver an isocratic mobile phase or a
gradient mobile phase
 Binary gradient pump
► delivers two solvents
 Quaternary gradient pump
► four solvents

SSJCP, Department of Pharmaceutical Analysis

147
 The pump is one of the most important component
of HPLC, since its performance directly affects
retention time, reproducibility and detector
sensitivity.
 Three main types of pumps are used in HPLC.
►Displacement pump
► Reciprocating pump
► Pneumatic (or) constant pressure pump
SSJCP, Department of Pharmaceutical Analysis

148
 DISPLACEMENT PUMP: It produce a flow that tends to
independent of viscosity and back pressure and also output
is pulse free but possesses limited capacity (250ml).
 RECIPROCATING PUMP: It has small internal volume (35400µl), their high output pressure(up to 10,000psi) and their
constant flow rates. But it produces a pulsed flow.
 PNEUMATIC (OR) CONSTANT PRESSURE PUMP:
► They are pulse free .
► Suffer from limited capacity as well as a dependence
of flow rate on solvent viscosity and column back
pressure.
► They are limited to pressure less than 2000 psi.
SSJCP, Department of Pharmaceutical Analysis

149
HPLC PUMPS – TWO BASIC TYPES
 Tandem piston
► Two pistons with different volumes (48 and 24 µL)
► During each stroke, 24 µL of liquid is delivered
► Best for higher analytical flow rates, up to 10 mL/min
► Some pulsation is observed, and pulse dampeners are
available
► Not recommended for pulse-sensitive detectors like
RID and CDD
SSJCP, Department of Pharmaceutical Analysis

150
TANDEM PISTON PUMP
Secondary
Piston ↓

← Primary Piston

SSJCP, Department of Pharmaceutical Analysis

151
DUAL PISTON
 Two pistons with equal volume (10 µL each)
 During each stroke, 10 µL is delivered
 Best for low flow rates (< 1 mL/min)
 Little to NO pulsation
 So it’s ideal for pulse sensitive detectors like RID and
CDD
SSJCP, Department of Pharmaceutical Analysis

152
DUAL PISTON

SSJCP, Department of Pharmaceutical Analysis

153
OTHER PUMP COMPONENTS
 Check Valves
► Control liquid movement in and out of the pump
head

SSJCP, Department of Pharmaceutical Analysis

154
 Piston/plunger seal
► Prevents solvent leakage out of pump head

 Inline filter
► Removes solvent particulates
SSJCP, Department of Pharmaceutical Analysis

155
VALVES USED WITH PUMPS
 Solvent Selection – 2 Solvents Per Pump
► Use for solvent switching

SSJCP, Department of Pharmaceutical Analysis

156
 Solvent Selection – 2 Solvents Per Pump
► Use for pump loading of large sample volumes

SSJCP, Department of Pharmaceutical Analysis

157
 Solvent Selection – 4 Solvents Per Pump
► Use for low pressure gradient formation

SSJCP, Department of Pharmaceutical Analysis

158
 Solvent Selection – 4 Solvents Per Pump
► Use for different gradients in method
development

SSJCP, Department of Pharmaceutical Analysis

159
SAMPLE INJECTION
SYSTEM
 There are three important ways of introducing
the sample in to the injection port.
► Loop injection : in which a fixed amount of
volume is introduced by making use of fixed
volume loop injector.
► Valve injection: in which, a variable volume is
introduced by making use of an injection valve.
► On column injection: in which, a variable
volume is introduced by means of a syringe
through a septum.

SSJCP, Department of Pharmaceutical Analysis

160
SSJCP, Department of Pharmaceutical Analysis

161
SAMPLE INJECTION – MANUAL
 Manual Injector with Syringe
► Fixed loop of varying sizes (1 to 20 mL or more)
► Fill with syringes of varying sizes
► Can include a switch to start a data system

SSJCP, Department of Pharmaceutical Analysis

162
SAMPLE INJECTION – AUTOMATIC
 Fixed-Loop Auto sampler
► Loop is installed on the valve and can be changed for different
injection volumes
► External syringe draws sample and fills loop
 Advantages:
► low cost
► rugged
► few moving parts
 Disadvantages:
► Poor performance for low volume injections higher
carryover
► always some sample loss
SSJCP, Department of Pharmaceutical Analysis

163
Sample Injection… how is a sample actually put into an LC system

 Manual Injector:
1. User manually loads sample into the injector using a syringe
and then turns the handle to inject sample into the flowing mobile
phase which transports the sample into the beginning (head) of
the column, which is at high pressure

 Autosampler:
1. User loads vials filled with sample solution into the autosampler
tray (100 samples) and the autosampler automatically :
2. measures the appropriate sample volume,
3. injects the sample,
4. then flushes the injector to be ready for the next sample, etc.,
until all sample vials are processed for unattended automatic
operation
SSJCP, Department of Pharmaceutical Analysis

164
SAMPLE INJECTION – FIXED LOOP
 External syringe draws sample, then fills the
fixed-volume loop attached to the valve.

SSJCP, Department of Pharmaceutical Analysis

165
 Needle-in-the-flow path auto sampler
► Sample loop and needle are a single piece of
tubing
► Loop and needle are cleaned during the run
► Metering pump draws sample very precisely
 Advantages:
► no sample loss,
► low carryover
 Disadvantages:
► higher cost
► more delay volume for gradient

SSJCP, Department of Pharmaceutical Analysis

166
SAMPLE INJECTION TO FLOW PATH

Sample Loading

SSJCP, Department of Pharmaceutical Analysis

167
RINSING AFTER INJECTION

Rinse liquid flows through ports 5
and 6 of the high pressure valve.

Sample aspiration uses port
5.
If air is present around port 5,
injection reproducibility will
be low.
Rinse
liquid
degassed!

SSJCP, Department of Pharmaceutical Analysis

MUST

be

168
%A
{H2O}

%B
%C
{MeOH}

Flow Rate Pressure
(mL/min)
(atmos.)

to column
load

Ready

inject

Rheodyne
Injector
Varian 9010 Solvent Delivery
System

to injector

through
pulse
dampener

Ternary
Pump
A

Column

through pump

C
B

SSJCP, Department of Pharmaceutical Analysis

from
solvent
reservoir

to
det
ect
or

169
CHROMATOGRAPHIC COLUMN
 The column is usually made up of heavy glass or stainless
steel tubule to withstand high pressure
 The columns are usually 10-30cm long and 4-10mm inside
diameter containing stationary phase at particle diameter of
25µm or less
 Column with internal diameter of 5mm give good results
because of compromise between efficiency, sample capacity,
and the amount of packaging and solvent required
SSJCP, Department of Pharmaceutical Analysis

170
 Within the Column is where separation occurs
 Key Point – Proper choice of column is critical for success in HPLC
 Types of columns in HPLC:
►Analytical [internal diameter (i.d.) 1.0 - 4.6-mm; lengths 15 – 250
mm]
► Preparative (i.d. > 4.6 mm; lengths 50 – 250 mm)
► Capillary (i.d. 0.1 - 1.0 mm; various lengths)
► Nano (i.d. < 0.1 mm, or sometimes stated as < 100 µm)
 Materials of construction for the tubing
► Stainless steel (the most popular; gives high pressure capabilities)
► Glass (mostly for biomolecules)
► PEEK polymer (biocompatible and chemically inert to most
solvents)
SSJCP, Department of Pharmaceutical Analysis

171
HPLC Columns Packing Materials
 Columns are packed with small diameter porous particles.
 The most popular sizes are: 5-μ m, 3.5- μ m and 1.8-μ m
 Columns are packed using high-pressure to ensure that they are stable
during use. Most users purchase pre-packed columns to use in their liquid
chromatographs

 These porous particles in the column usually have a chemically bonded
phase on their surface which interacts with the sample components to separate
them from one another for example, C18 is a popular bonded phase

 The process of retention of the sample components (often called analytes) is
determined by the choice of column packing and the selection of the mobile
phase to push the analytes through the packed column.

SSJCP, Department of Pharmaceutical Analysis

172
HPLC COLUMN OVENS
 Block heater with solvent preheater
► Column is housed between 2 metal plates
► Mobile phase is plumbed into the block for
preheating
 Forced air
► Column is in a large chamber with air
circulation
► Better temperature equilibration
► Room for column switching valves
SSJCP, Department of Pharmaceutical Analysis

173
Why Use a Column Oven?
 Retention times decrease & higher flow rates
possible
2.1 mm ID Column, 0.35 mL/min, 50/50 MeOH/Water
50°C
45°C
40°C
35°C
30°C
25°C
20°C

SSJCP, Department of Pharmaceutical Analysis

174
DETECTORS
 The function of detector in HPLC is to monitor the mobile phase
as it merges from the column.
 Detectors are usually of two types:
► Bulk property detectors: It compares overall changes in a
physical property of the mobile phase with and without an
eluting solute e.g. refractive index ,dielectric constant or density.
► Solute property detectors: It responds to a physical property of
the solute which is not exbited by the pure mobile phase.e.g.UV
absorbance,fluoroscence or diffusion current.
SSJCP, Department of Pharmaceutical Analysis

171
175
TYPES OF DETECTORS
There are mainly 4 types of detectors are used in HPLC:
 Photometric detectors.
► Single wavelength detectors.
► Multi wavelength detectors.
► Variable wavelength detectors.
► Programmable detectors.
► Diode array detectors .
 Fluorescence detectors.
 Refractive index detectors.
 Electrochemical detectors.
 Evaporative light scattering detectors
 IR detectors
 UV detectors
SSJCP, Department of Pharmaceutical Analysis

176
PHOTOMETRIC DETECTORS
 These normally operate in the ultra violet
region of the spectrum .
 Most extensively used in pharmaceutical
analysis.
SSJCP, Department of Pharmaceutical Analysis

177
SINGLE WAVELENGTH DETECTORS

 Equipped with a low pressure mercury
discharge lamp.
 The absorbance is measured at the
wavelength of mercury at 254 nm.
SSJCP, Department of Pharmaceutical Analysis

178
MULTI WAVELENGTH DETECTORS
 Employ mercury and other discharge
sources.
 When used in combination with
interference filters allow a no of
monochromatic wavelengths to be
selected e.g. 206, 226, 280 , 313, 340 or 365
nm.
SSJCP, Department of Pharmaceutical Analysis

179
Multi-wavelength UV-Vis Absorption
Detector

Deuterium
Lamp

SSJCP, Department of Pharmaceutical Analysis

Photodiode
Array

180
VARIABLE WAVELENGTH
DETECTORS
 Use a deuterium light source.
 A grating monochromator to allow selection of
any wavelength in deuterium continuum
(190-360 nm).

SSJCP, Department of Pharmaceutical Analysis

177
181
UV-VISIBLE DETECTOR
 UV-Visible
► Wavelength range 190-700 nm
► D2 and W lamps
 Most common HPLC detector for a variety of samples
► Proteins and peptides
► Organic molecules
► Pharmaceuticals
 Monitor two wavelengths at one time
SSJCP, Department of Pharmaceutical Analysis

182
UV-Visible Detector

SSJCP, Department of Pharmaceutical Analysis

183
Variable wavelength detector

SSJCP, Department of Pharmaceutical Analysis

184
Variable UV/Vis Detector
ABS AUFS λ RunTime EndTime
0.001 2.000 238 0.00 min 10.0 min
Ready

SSJCP, Department of Pharmaceutical Analysis

185
PROGRAMMABLE DETECTORS
 Allow the automatic change of
wavelength between and during the
chromatographic analysis.

SSJCP, Department of Pharmaceutical Analysis

186
DIODE ARRAY DETECTORS
 They are microprocessor – controlled
photodiode array spectrophotometers in
which light from an UV source passes
through the flow cell into a polychromator
which disperses the beam so that the full
spectrum falls on the array of diodes.

SSJCP, Department of Pharmaceutical Analysis

183
187
DIODE ARRAY DETECTOR
 Wavelength range 190-900 nm
 D2 and W lamps
 Spectral information about sample
 Create compound libraries to identify unknowns
 Monitor an entire wavelength range at one time – up to
790 wavelengths vs. only 2 with a UV detector
SSJCP, Department of Pharmaceutical Analysis

188
DIODE ARRAY DETECTOR

SSJCP, Department of Pharmaceutical Analysis

189
FLUORESCENCE DETECTOR
 These are essentially filter fluorimeter or
spectro -fluorimeters equipped with
grating monochromators, and micro flow
cell.
 Their sensitivity depends on the
fluorescence properties of the components
in the elute.
SSJCP, Department of Pharmaceutical Analysis

190
 Fluorescence detector
► Xenon lamp for light source
► Excitation wavelength range: 200-650 nm
► Emission wavelength range: up to 900 nm depending on
photomultiplier installed

 Used primarily for amino acid analysis
► Derivatize samples before (pre-column) or after
separation( post-column)
SSJCP, Department of Pharmaceutical Analysis

191
Fluorescence Detector

SSJCP, Department of Pharmaceutical Analysis

192
REFRACTIVE INDEX DETECTORS
 Which respond to the change in the bulk
property of the refractive index of the solution of
the component in the mobile solvent system.
 The sensitivity of the refractive index detector
is much less than that of specific solute property
detectors, they are useful for the detection of
substances(e.g ,carbohydrates & alcohols) which
do not exhibit other properties that can be used
as the basis for specific detection.
SSJCP, Department of Pharmaceutical Analysis

193
Refractive Index Detector
 For samples with little or no UV Absorption
 Alcohols, sugars, saccharides, fatty acids, polymers
 Best results when RI of samples is very different from RI of mobile
phase
 Flow cell is temperature controlled with a double insulated
heating block
 Requires isocratic separations
 Requires low pulsation pumps
SSJCP, Department of Pharmaceutical Analysis

194
RI BALANCE
 Fill sample and reference cell with mobile phase

SSJCP, Department of Pharmaceutical Analysis

195
RI ANALYZE
 Mobile phase flows through sample side only
 As the refractive index changes, the image on the photodiode is
deflected or “unbalanced”, and the difference in current to the photodiode
is measured.

SSJCP, Department of Pharmaceutical Analysis

196
Refractive Index Detector

SSJCP, Department of Pharmaceutical Analysis

197
ELECTROCHEMICAL DETECTORS
 These are based on standard electrochemical
principles involving amperometry,voltametryand
polarography.
 These detectors are very sensitive for substances
that are electroactive ,i.e. those that undergo
oxidation or reduction .
 They have found particular application in the assay
of low levels of endogenous catecholamines in
biological tissues,pesticides,tryptophan derivatives
and many drugs.
SSJCP, Department of Pharmaceutical Analysis

198
Electrochemical Detector

SSJCP, Department of Pharmaceutical Analysis

199
EVAPORATIVE LIGHT SCATTERING (ELSD)
 Also for low or no UV absorbing compounds
 Sometimes called a “Universal” detector
 Requires NO equilibration (unlike RID)
 Can be used with gradients and volatile buffers (unlike
RID)
 Semi-volatile compounds can be detected at low
temperatures
SSJCP, Department of Pharmaceutical Analysis

200
ELSD OPERATION
Column
Effluent

Nebulizer

Nebulizer Gas
(Air or Nitrogen)

Nebulization Chamber

Analyte

Drift Tube
(Heated Zone Evaporation Area)

PMT
Light Source

Amplifier
Light
Scattering
Cell

SSJCP, Department of Pharmaceutical Analysis

Signal
Output

201
ELSD v/s OTHER DETECTORS

 ELSD has higher sensitivity than UV and RID

 ELSD can be used with gradients, unlike RID

SSJCP, Department of Pharmaceutical Analysis

202
CONDUCTIVITY DETECTOR
 Flow cell contains 2 electrodes
 Measure ion amounts in sample
 REQUIRES low pulsation pumps
 Flow cell must be placed in a column oven
SSJCP, Department of Pharmaceutical Analysis

203
 Use in Environmental and water testing
► Fl-, Cl- NO3-, PO43-, SO42► Li+, Na+, K+, Mg2+, Cu2+, M-CN
complexes
 Determine organic acids in fruit juice
► Oxalic, Maleic, Malic, Succinic,
Citric
 Analyze surfactants
► Sulfonates, long/short chain
ammonium
SSJCP, Department of Pharmaceutical Analysis

204
Mass Spectrometer Detector
 Separate sample components as ions according to their mass to
charge (m/z) ratio
 Three stages to detection
 Vaporization: liquid from HPLC column converted to an aerosol
 Ionization: neutral molecules converted to charged species (either
positive or negative)
 Mass Analysis: filter ions by m/z ratio
SSJCP, Department of Pharmaceutical Analysis

205
TWO IONIZIZATION TYPES
 APCI: Atmospheric Pressure Chemical Ionization
► For molecules up to 1000 Da
► Singly charges ions
► Best for analysis of non-polar molecules

 ESI: Electrospray Ionization
► Can be used for large biopolymers
► Forms multiply charged ions
► Best for the analysis of polar molecules, especially
pharmaceutical products and proteins
SSJCP, Department of Pharmaceutical Analysis

206
MS DETECTOR
Heated
capillary

Q-array

Orthogonal source
geometry

Octapole

Electron Multiplier
Detector

Quadrupole mass analyser

SSJCP, Department of Pharmaceutical Analysis

207
FRACTION COLLECTOR
 Purify raw materials or compounds from
synthesis
 Collect by slope, level, time, volume
 Isolate single peaks per tube, or divide peaks
into small “slices” for extra purity

SSJCP, Department of Pharmaceutical Analysis

208
Temperature Control in HPLC: Why is it needed?
 Reproducibility
► Retention in HPLC is temperature-dependent
► If temperature varies, then it is difficult to assign “peaks” to specific
compounds in the chromatogram and the peak areas/heights may vary
 Solubility
► Certain chemical compounds may have low solubility in the HPLC
mobile phase
► If they are injected into the flow stream they may precipitate or other
difficulties may arise
 Stability
► Certain chemical compounds, especially biological compounds such as
enzymes or proteins, may not be stable at room temperature or higher
► The temperature needs to be much lower down to 4°C

SSJCP, Department of Pharmaceutical Analysis

209
How is Temperature Control Achieved?
 Three (3) ways the temperature of a column
could be controlled, use:
► Oven
► Heater Block
► Water bath
SSJCP, Department of Pharmaceutical Analysis

210
What is HPLC used for?
 Separation and analysis of non-volatile or
thermally-unstable compounds
 HPLC is optimum for the separation of chemical
and biological compounds that are non-volatile
 NOTE: If a compound is volatile (i.e. a gas,
fragrance, hydrocarbon in gasoline, etc.), gas
chromatography is a better separation technique.
SSJCP, Department of Pharmaceutical Analysis

211
 Typical non-volatile compounds are:
► Pharmaceuticals like aspirin, ibuprofen, or
acetaminophen (Tylenol)
► Salts like sodium chloride and potassium phosphate
► Proteins like egg white or blood protein
► Organic chemicals like polymers (e.g. polystyrene,
polyethylene)
► Heavy hydrocarbons like asphalt or motor oil
► Many natural products such as ginseng, herbal
medicines, plant extracts
► Thermally unstable compounds such as trinitrotoluene
(TNT), enzymes etc….
SSJCP, Department of Pharmaceutical Analysis

212
FOR QUALITATIVE ANALYSIS
 The identification(ID) of individual compounds
in the sample;
► the most common parameter for compound
ID is its retention time (the time it takes for
that specific compound to elute from the
column after injection);
►

depending on the detector used, compound
ID is also based on the chemical structure,
molecular weight or some other molecular
parameter.
SSJCP, Department of Pharmaceutical Analysis

213
FOR QUANTITATIVE ANALYSIS
 The measurement of the amount of a compound in a sample
(concentration); meaning, how much is there?

 There are two main ways to interpret a chromatogram (i.e.
perform quantification):

► determination of the peak height of a chromatographic peak
as measured from the baseline;

► determination of the peak area (see figure below);
 In order to make a quantitative assessment of the compound,
a sample with a known amount of the compound of interest is
injected and its peak height or peak area is measured.

 In many cases, there is a linear relationship between the
height or area and the amount of sample.
SSJCP, Department of Pharmaceutical Analysis

214
Preparation of Pure Compound(s)
 By collecting the chromatographic peaks at the exit of
the detector
 and concentrating the compound (analyte) by
removing/evaporating the solvent
 a pure substance can be prepared for later use (e.g.
organic synthesis, clinical studies, toxicology studies,
etc….).
 This methodology is called preparative chromatography.
SSJCP, Department of Pharmaceutical Analysis

215
Trace analysis
 A trace compound is a compound that is of interest to the
analyst but it’s concentration is very low, usually less than 1% by
weight, often parts per million (ppm) or lower;
 the determination of trace compounds is very important in
pharmaceutical, biological, toxicology, and environmental studies
since even a trace substance can be harmful or poisonous;
 in a chromatogram trace substances can be difficult to separate
or detect;
 high resolution separations and very sensitive detectors are
required
SSJCP, Department of Pharmaceutical Analysis

216
SSJCP, Department of Pharmaceutical Analysis

217
SEPARATION TECHNIQUES IN HPLC METHOD
DEVELOPMENT

GOAL

COMMENT

Resolution

Precise and rugged quantitative analysis
requires that Rs be greater than 1.5

Separation time

3-10 min is desirable for routine procedures

Quantitation

≤2% for assays; ≤ 5% for less-demanding
analyses; ≤ 15% for trace analyses

Peak Height

Narrow peaks are
signal/noise ratios

Solvent composition

Minimum mobile-phase use per run is
desirable

desirable

SSJCP, Department of Pharmaceutical Analysis

for

large

218
THE VALIDATION PROCESS
► It consists of four distinct steps:
Software validation
Hardware (instrumentation)
validation/qualification
Method validation
System suitability
SSJCP, Department of Pharmaceutical Analysis

219
HPLC SYSTEM QUALIFICATION

SSJCP, Department of Pharmaceutical Analysis

220
GOALS FOR AN IMPROVED ANALYTICAL
METHOD DEVELOPMENT
► Qualitative identification - structural information,
retention time, color change, pH etc
► Quantitative determination - accurate, precise and
reproducible in any laboratory settings
► Ease of use, viability to be automated, high sample
throughput, and rapid sample turnaround time.
► Decreased cost per analysis - using simple quality
assurance and quality control procedures
SSJCP, Department of Pharmaceutical Analysis

221
► Sample preparation minimizing - time, effort, materials,
and volume of sample consumed
► Direct output of qualitative or quantitative data evaluations, interpretation, printing out and transmission

OPTIMIZATION & ANALYTICAL FIGURES OF MERIT
► initial sets of conditions - resolution, peak shape, plate
counts, asymmetry, capacity, elution time, detection
limits
► quantifying the specific analyte of interest, accuracy and
precision of Quantitation and specificity must be defined.
SSJCP, Department of Pharmaceutical Analysis

222
► Chromatographic resolution adequate
► Limits of detections are lower
► Calibration plots are linear
► Sample throughout is increased
► Sample preparation before analysis is minimized
► Interference is minimized and identified
► Data acquisition - translated, interpreted, printed & stored
► Reproducibility of analytical figures of merit & Cost per analysis is
minimized

SSJCP, Department of Pharmaceutical Analysis

223
METHOD VALIDATION APPROACHES
► Samples of the given analyte
► Concentration in the matrix
► High degree of accuracy and precision
► Zero, Single and Double –Blind spiking methods
► Inter laboratory collaborative studies
► Comparison with a currently accepted compendium method
SSJCP, Department of Pharmaceutical Analysis

224
STEP-BY-STEP HPLC METHOD DEVELOPMENT, OPTIMIZATION
AND VALIDATION: AN OUTLINE
► Analyte Standard Characterization
► Method Requirements
► Literature Search and Prior Methodology
► Choosing a Method
► Instrument Setup and Initial Studies
► Optimization
► Demonstration of Analytical Figures of Merit with Standards
SSJCP, Department of Pharmaceutical Analysis

225
► Evaluation of Method Development with Actual Samples and
Derivation of Figures of Merit
► Validation of Figures of Merit
► Determination of Percent Recovery of Actual Sample and
Demonstration of Quantitative Sample Analysis
► Method Validation
► Preparation of Written Protocols and Procedures
► Transfer of Method Technology to Outside Laboratories and
Interlaboratory Collaborative Studies
SSJCP, Department of Pharmaceutical Analysis

226
► Comparison of Interlaboratory Collaborative Studies
► Preparation of Summary Report on Overall Method Validation
Results
► Summary Report of Final Method and Validation Procedures and
Results and also Preparation of Journal Article for Submission
THE OUTLINE PROTOCOL OF HPLC METHOD

SSJCP, Department of Pharmaceutical Analysis

227
STEPS FOR HPLC METHOD DEVELOPMENT
Information on sample, define
separation goals

Validate method for release to
routine laboratory

Need for special procedure
sample pretreatment, etc

Quantitative calibration

Choose detector and detector
settings

Choose LC method; preliminary
run; estimate the best
separation conditions

Check
for
problems
or
requirement
for
special
procedure

Optimize separation conditions

SSJCP, Department of Pharmaceutical Analysis
PARAMETERS USED IN METHOD VALIDATION

SSJCP, Department of Pharmaceutical Analysis

229
SPECIFICITY
► It is the ability to measure accurately and specifically the analyte
of interest in the presence of other components that may be
expected to be present in the sample matrix
► Specificity is also measured and documented in a separation by
the resolution, plate count (efficiency) and tailing factor
► Blank solution to show no interference with excipients or
degradation products or impurities
► Placebo to demonstrate the lack of interference from excipients
► Spiked samples to show that all known related substances are
resolved from each other
SSJCP, Department of Pharmaceutical Analysis

230
LINEARITY AND RANGE
► It is the ability of the method to elicit test results that are directly
proportional to analyte concentration within a given range
► Reported as the variance of the slope of the regression line
► ICH guidelines specify a minimum of five concentration levels
► Assay : 80-120% of the theoretical content of active
Content Uniformity: 70-130%
► Dissolution: ±20% of limits; e.g if limits cover from 20% to 90% l.c.
(controlled release), linearity should cover 0-110% of l.c.
SSJCP, Department of Pharmaceutical Analysis

231
► Impurities: reporting level to 120% of shelf life limit
► Assay/Purity by a single method: reporting level of the
impurities to 120% of assay limit
► Correlation coefficient (r) = API: ≥ 0.998 & Impurities: ≥
0.99
► y-intercept and slope should be indicated together with
plot of the data

SSJCP, Department of Pharmaceutical Analysis

232
ACCURACY
► Measure of exactness of an analytical method or closeness of
agreement between the measured value and the value that is
accepted either as a conventional, true value or an accepted
reference value
► Measured as percentage of analyte recovered by assay, by spiking
samples in a blind study
► API (Active Pharmaceutical Ingredient): against an RS (Reference
Standard) of known purity, or via an alternate method of known
accuracy; analysis in triplicate
► FPP (Finished Pharmaceutical Product): samples/placeboes spiked
with API, across the range of 80-120% of the target concentration, 3
concentrations, in triplicate each
SSJCP, Department of Pharmaceutical Analysis

233
► Report % recovery (mean result and RSD): 100±2%
► Impurities: API/FPP spiked with known impurities
► Across the range of LOQ-150% of the target
concentration (shelf life limit), 3-5 concentrations, in
triplicate each. (LOQ, 50%, 100%, 150%)
► % recovery: in general, within 80-120%, depends on the
level of limit
► ICH Q2 states: accuracy may be inferred once precision,

linearity and specificity
SSJCP, Department of Pharmaceutical Analysis

234
LOD / LOQ
► LOD: the lowest concentration of an analyte in a sample that can
be detected though not necessarily quantitated.
► LOQ: the lowest concentration of an analyte in a sample that can
be determined with acceptable precision and accuracy under the
stated operational conditions of the method

► signal to noise ratio: LOD = 3:1 , LOQ = 10:1

● May vary with lamp aging, model/manufacturer of detector, column

► standard deviation of the response and the slope of the calibration
curve at levels approximating the LOD /LOQ

● σ = the standard deviation of the response, based on the standard deviation of the blank & the calibration curve & S =
Slope

SSJCP, Department of Pharmaceutical Analysis
► should be validated by analysis of samples at the limits
► LOD: below the reporting threshold
► LOQ: at or below the specified limit
► Not required for assay/dissolution methods
► Applicant should provide
● the method of determination
● the limits
● chromotograms
SSJCP, Department of Pharmaceutical Analysis

236
ROBUSTNESS / RUGGEDNESS
► Robustness: capacity of a method to remain unaffected
by small deliberate variations in the method parameters
► Ruggedness: degree of reproducibility of the results
obtained under a variety of conditions, expressed as % RSD
► Evaluated by varying method parameters such as percent
organic solvent, pH, ionic strength or temperature ,
determining the effect on the results of the method,
columns, laboratories, analysts, instruments, reagents and
experimental periods.
SSJCP, Department of Pharmaceutical Analysis

237
SYSTEM SUITABILITY TESTING (SST)
► used to verify resolution, column efficiency, and
repeatability of the analysis system to ensure its adequacy
for performing the intended application on a daily basis.
►Parameters:
● Number of theoretical plates (efficiency)
● Capacity factor
● Separation (relative retention)
● Resolution
● Tailing factor
● Relative Standard Deviation (Precision)
SSJCP, Department of Pharmaceutical Analysis

238
Center for Drug Evaluation and Research (CDER) Limits for SST

SSJCP, Department of Pharmaceutical Analysis

239
CHARACTERISTICS TO BE VALIDATED IN HPLC
CHARACTERISTICS

ACCEPTANCE CRITERIA

Accuracy/trueness

Recovery 98-102% with 80, 100 &
120% spiked sample

Repeatability

RSD < 2%

Intermediate precision

RSD < 2%

Specificity/selectivity

No interference

Detection limit

S/N > 2 or 3

Quantitation limit

S/N > 10

Linearity

Correlation coefficient r > 0.999

Range

80 – 120%

Stability of sample solution

> 24 hours or > 12 hours

SSJCP, Department of Pharmaceutical Analysis

240
TYPICAL HPLC INSTRUMENT VERIFICATION
REPORT
TEST ITEM
USER LIMIT
ACTUAL LIMIT
DAD noise

< 5 X 10-5 AU

1 X 10-5 AU

Baseline drift

< 2x 10-3 AU/hour

1.5 X 10-4 AU/hour

DAD WL calibration

± 1 nm

± 1 nm

DAD linearity

1.5 AU

2.2 AU

Pump performance

< 0.3% RSD RT

0.15% RSD RT

Temperature
stability
± 0.15° C
(column heater)

± 0.15° C

Precision of peak area

0.09% RSD

0.5% RSD

SSJCP, Department of Pharmaceutical Analysis

241
METHOD VALIDATION PROTOCOL
1. On day 1, a linearity test over 5 levels for both the drug
substance (bulk) and dosage form is performed
2. Comparison of the results between the drug substance
and dosage form fulfills the accuracy requirement
3. At the end of day 1, 6 repetitions are performed at 100%
of the drug substance for repeatability
4. Steps 1 and 2 are repeated over 2 additional days for
intermediate precision
5. LOQ is evaluated by analyzing the drug substance over 5
levels, plus 6 repetitions for precision
6. Baseline noise is evaluated over 6 repetitions of blank
injections for the determination of LOD.
SSJCP, Department of Pharmaceutical Analysis

242
TROUBLE SHOOTING
(TIPS & FACTS)
ASK PULLA

For any further clarification or details of
the below content(s) feel free to mail me :

ravipratappulla@gmail.com
SSJCP, Department of Pharmaceutical Analysis

243
1.What is HPLC anyway?
2. How to become friendly with your HPLC equipment?
3. How to get started?
4. Which column do I have to install in the HPLC
instrument?
5. How do I prepare a mobile phase?
6. What is the requirement of equilibrating the system
before the advent of sample preparation.
7. What do I have to pay attention to before starting a
measurement?
8. How do I start working with the HPLC equipment?
9. What's the reason for quitting your HPLC system?
SSJCP, Department of Pharmaceutical Analysis

244
SIMPLE TESTS & DECISION CRITERIA
10.What does the name of a column tell us?
11. Is this C18 column the right choice for my sample?
12. Why are polar solutes well separated with one C18 column and
hardly at all with another?
13. How can I clean the RP Phase quickly?
14. How best do I degas my mobile phase?
15. Methanol or Acetonitrile? Best choice of solvent…..?
16. The pH of the mobile phase too high or too low. What can I do?
17.What is the right ionic strength of the buffer?
18.How to make sense of the dead volume of an isocratic apparatus?
19.Producing a gradient chromatogram – influence of
instrumentation?
20. Does the pump work correctly, precisely or accurately?
SSJCP, Department of Pharmaceutical Analysis

245
21. How to test an HPLC instrument and its modules?
22. Injections of solutes as an aqueous solutions?
23. What is the largest tolerable injection volume?
24 . How critical are the temperature changes?
25. How to choose HPLC equipment and a supplier?
26. Is the current method a robust one?

PROBLEMS & THEIR SOLUTIONS
27. Sample preparation – how critical are which mistakes?
28. Flushing of an HPLC equipment?
29. Dirt in the UV detection cell?
30. The lamp is new – what happened to the peak?
31. What are the causes of pressure changes or deviations?
SSJCP, Department of Pharmaceutical Analysis

246
32. Is the right or the left pump head defective?
33. Baseline noise and damping?
34. The retention times increase- is it the pump or the M.P ?
35. Which buffer is right for which pH?
36. An interesting alternative for the separation of acids & bases
with a buffer…..
37. What can be the reasons for a change in retention times?
38. I use up a lot of RP columns; what should I do?
39. Why does my NP system not work any more?
40. Chemical tailing at the presence of metal ions?
41. How to avoid memory effects?
42. How do the default values on my PC affect the resolution?
SSJCP, Department of Pharmaceutical Analysis

247
TIPS TO OPTIMIZE THE SEPARATION
43. Which is the right injection techniques to get sharper peaks?
44. My peaks appear too early – how can I move them in an RP
system to later retention times?
45. How can I increase the plate number?
46. Limit of detection: How can I see more?
47. How can I speed up a separation?
48. How can I optimize a separation?
49. Dead volume capacity, capacity factor, selectivity – how can I use
them in everyday life?
50. Which flow is optimal for me?
51. How can I optimize a gradient elution?
52. Separation of ionic solutes? What works out best –end capped
phases, inert phases, phosphate buffer or ion pairing reagents?
SSJCP, Department of Pharmaceutical Analysis

248
SITUATION/SYMPTOM/CAUSE
EQULIBRATION
53. SLOW COLUMN
 RP- Ion pairing long chain

54.VARYING / VARIABLE RETENTION TIMES








gradient insufficient column regeneration time
ion pairing insufficient equilibration time
isocratic insufficient equilibration time
irregular column equilibration time
Leak
change in M.P composition
air trapped in pump
SSJCP, Department of Pharmaceutical Analysis

249
 buffer capacity insufficient
 contamination buildup
 equilibration time insufficient for gradient run or changes in
isocratic M.P
 first few injections – active sites
 inconsistent online M.P mixing or delivery
 selective evaporation of M.P component
 varying column temperature
 check valve malfunctioning
 pump cavitations, phase collapse (de-wetting process)
 Column temperature fluctuations
 First few injections adsorption on active sites
 column overloading
 sample solvent incompatible with M.P
SSJCP, Department of Pharmaceutical Analysis

250
 Column problem
 improper M.P
 column aging

55. INCREASED RETENTION TIME










decreasing flow rate,
changing M.P composition,
loss of bonded S.P,
active sites on column packing
Low M.P flow rate
Column temperature low
Improper gradient setting
Column activity increasing
System not equilibrated
SSJCP, Department of Pharmaceutical Analysis

251






M.P removing water from LSC column
Incorrect M.P
Loss of bonded S.P
M.P composition changing
Active sites on silica packing

56. DECREASED RETENTION TIME








column overloaded with sample
increasing flow rates
loss of bonded S.P or base silica from column
column aging,
basic compounds – pH too low
High M.P flow rate
Column temperature high
SSJCP, Department of Pharmaceutical Analysis

252







Improper gradient
Incorrect M.P
Column activity decreased
System not equilibrated
Deactivation by strongly retained garbage
Too strong sample solvent

57. RETENTION BEYOND TOTAL PERMEATION
VOLUMES
 SEC – solute interaction with S.P.

SSJCP, Department of Pharmaceutical Analysis

253
58. LOSS OF RESOLUTION











M.P contaminated/deteriorated
Obstructed guard or analytical column
Column overload with sample
Degraded column
Column not fully equilibrated
Loss of S.P from the column
Dirty column
Loss of column liquid phase
Distorted column bed
Wrong column or M.P

SSJCP, Department of Pharmaceutical Analysis

254
SENSITIVITY
59. Lack of sensitivity
 auto sampler flow lines blocked
 detector attenuation set too high
 first few samples injections
 sample adsorption in injector sample loop or column
 injector sample loop under filled
 not enough sample injected
 peak signals are outside
 detector’s linear range
 sample losses during sample preparation
 sample losses on column peak too broad

SSJCP, Department of Pharmaceutical Analysis

255
BASELINE
60. Distribution At Void
 air bubbles in M.P
 positive-negative differences in RI of injection solvent & M.P

61. BASELINE DRIFT
 Column temperature fluctuations
 Non homogeneous M.P
 Contaminant or air buildup in detector, sample or reference cell
 Plugged outlet line after detector
 M.P mixing problem or change in flow rate
 Slow column equilibration when changing M.P
 M.P contaminated or deteriorated or not prepared from high
quality chemicals
SSJCP, Department of Pharmaceutical Analysis

256
 Strongly retained materials in sample can elute as very broad
peaks and appear to be a rising baseline
 Detector not set at absorbance maximum but at slope of curve
 M.P or sample vaporizing
 Failing detector source
 Detector problem
 Solvent immiscibility
 Contamination bleed in system
 Solvent demixing
 Slow change in pump output
 Partial plugging of injection port or sample valve or column inlet
by particulate matter
 Contaminated or bleed column
 Contamination in detector cell
SSJCP, Department of Pharmaceutical Analysis

257







Change in detector temperature
Malfunction of detector source
Contamination in solvent reservoir
Previous M.P not removed
Negative direction
Positive direction

62. BASELINE NOISE (REGULAR)








Air in M.P or detector cell or pump
Pump pulsations
Incomplete M.P mixing
Temperature effect
Other electronic equipment on same line
Leak or partial blockage of loop injector valve or detector lamp problem
Dirty flow cell

SSJCP, Department of Pharmaceutical Analysis

258
63. BASELINE NOISE (IRREGULAR)
 Leak
 M.P contaminated or deteriorated or prepared from low quality
materials
 Detector or recorder electronics
 Air trapped in system
 Air bubbles in detector
 Detector cell contaminated
 Weak detector lamp
 Column leaking silica or packing material or column packing
passing through detector
 Continuous detector lamp problem or dirty in the flow cell
 gradient or isocratic proportioning - lack of solvent mixing &
malfunctioning proportioning valves
SSJCP, Department of Pharmaceutical Analysis

259
 occasional sharp spikes,
 external electric interferences,
 periodic pump pulse,
 random contamination buildup,
 spikes – bubble in detector & column temperature higher than B.P
of solvent

RECOVERY
64. POOR SAMPLE RECOVERY
 absorption or adsorption of proteins
 adsorption on column packing
 absorption on tubing and other hardware components
 chemisorption on column packing
 hydrophobic interactions between S.P & biomolecules
SSJCP, Department of Pharmaceutical Analysis

260
 less than 90% yield for acidic compounds irreversible adsorption
on active sites
 less than 90% yield for basic compounds irreversible adsorption
on active sites

LEAKS
65. LEAKY FITTING






A loose fitting
Stripped fitting
Over tighten fitting
Dirty fitting
Mismatched part/fitting
SSJCP, Department of Pharmaceutical Analysis

261
66. LEAKS AT PUMP







Loose check valve
Mixer seal failure
Pump seal failure
Pressure transducer failure
Pulse damper failure
Proportioning valve failure

67. INJECTOR LEAKS







Rotor seal failure
Blocked loop
Loose injection port seal
Improper syringe needle diameter
Waste line siphoning
Waste line blockage
SSJCP, Department of Pharmaceutical Analysis

262
68. COLUMN

LEAKS

 Loose end fittings
 Column packing in ferrule
 Improper frit thickness
69. DETECTOR





LEAKS

Cell gasket failure
Cracked cell window
Leaky fittings
Blocked waste line
SSJCP, Department of Pharmaceutical Analysis

263
PROBLEMS DETECTED BY
SMELL, SIGHT & SOUND
70. SOLVENT SMELL
 Leak
 Spill
71. HOT SMELL
 Overheating
72. ABNORMAL METER READING
 Pressure abnormality
 Column oven
 Detector lamp failing
73. WARNING LAMP
 Pressure limits exceeded
 Other warning signals
SSJCP, Department of Pharmaceutical Analysis

264
HPLC
HPLC
HPLC
HPLC
HPLC
HPLC
HPLC
HPLC
HPLC
HPLC
HPLC
HPLC
HPLC
HPLC
HPLC
HPLC
HPLC
HPLC
HPLC
HPLC
HPLC
HPLC
HPLC
HPLC
HPLC
HPLC
HPLC
HPLC
HPLC
HPLC
HPLC
HPLC
HPLC
HPLC
HPLC
HPLC
HPLC
HPLC
HPLC
HPLC

Contenu connexe

Tendances (20)

Columns in HPLC
Columns in HPLCColumns in HPLC
Columns in HPLC
 
Nano LC and UPLC
Nano LC and UPLCNano LC and UPLC
Nano LC and UPLC
 
HPLC method development
HPLC method developmentHPLC method development
HPLC method development
 
HPLC Column
HPLC ColumnHPLC Column
HPLC Column
 
Hplc
Hplc Hplc
Hplc
 
Ion pair chromatography final
Ion pair chromatography finalIon pair chromatography final
Ion pair chromatography final
 
Nano liquid chromatography (ncl)
Nano liquid chromatography (ncl)Nano liquid chromatography (ncl)
Nano liquid chromatography (ncl)
 
General considerations and method development in ce,
General considerations and method development in ce,General considerations and method development in ce,
General considerations and method development in ce,
 
Bioanalytical method validation emea
Bioanalytical method validation emeaBioanalytical method validation emea
Bioanalytical method validation emea
 
Kaumil Hplc
Kaumil   HplcKaumil   Hplc
Kaumil Hplc
 
Hyphenated techniques
Hyphenated techniquesHyphenated techniques
Hyphenated techniques
 
validation and calibration of HPLC
validation and calibration of HPLCvalidation and calibration of HPLC
validation and calibration of HPLC
 
Method-Validation-HPLC-case-study
Method-Validation-HPLC-case-studyMethod-Validation-HPLC-case-study
Method-Validation-HPLC-case-study
 
Lc ms
Lc msLc ms
Lc ms
 
Hplc troubleshooting converted
Hplc troubleshooting convertedHplc troubleshooting converted
Hplc troubleshooting converted
 
ultra performance liquid chromatography ppt.by Manoj Ingale
ultra performance liquid chromatography ppt.by Manoj Ingaleultra performance liquid chromatography ppt.by Manoj Ingale
ultra performance liquid chromatography ppt.by Manoj Ingale
 
hplc trouble shooting - final.ppt
hplc trouble shooting - final.ppthplc trouble shooting - final.ppt
hplc trouble shooting - final.ppt
 
HPLC-COLUMNS
HPLC-COLUMNS HPLC-COLUMNS
HPLC-COLUMNS
 
Trouble shooting
Trouble shootingTrouble shooting
Trouble shooting
 
Analytical method development
Analytical method developmentAnalytical method development
Analytical method development
 

Similaire à HPLC

Recent advancement in impurity profiling
Recent advancement in impurity profilingRecent advancement in impurity profiling
Recent advancement in impurity profilingPiramal Healthcare
 
Simultaneous estimation of uv spectroscopy and method development and validat...
Simultaneous estimation of uv spectroscopy and method development and validat...Simultaneous estimation of uv spectroscopy and method development and validat...
Simultaneous estimation of uv spectroscopy and method development and validat...Shiva sai kiran
 
Shahid Ayoub.. HPTLC PPT
Shahid Ayoub.. HPTLC PPTShahid Ayoub.. HPTLC PPT
Shahid Ayoub.. HPTLC PPTShahid Ayoub
 
عرض تحليل الي م3_095500.pptx
عرض تحليل الي م3_095500.pptxعرض تحليل الي م3_095500.pptx
عرض تحليل الي م3_095500.pptxawasbelal
 
عرض تحليل الي م3_095500.pptx
عرض تحليل الي م3_095500.pptxعرض تحليل الي م3_095500.pptx
عرض تحليل الي م3_095500.pptxawasbelal
 
High Performance Liquid Chromatography HPLC
High Performance Liquid Chromatography HPLCHigh Performance Liquid Chromatography HPLC
High Performance Liquid Chromatography HPLCijtsrd
 
HPLC Presentation by moun
HPLC Presentation by mounHPLC Presentation by moun
HPLC Presentation by mounrafamoun
 
HPLC (HIGH PERFORMANCE LIQUID CHROMATOGRAPHY)
HPLC (HIGH PERFORMANCE LIQUID CHROMATOGRAPHY)HPLC (HIGH PERFORMANCE LIQUID CHROMATOGRAPHY)
HPLC (HIGH PERFORMANCE LIQUID CHROMATOGRAPHY)royal college of pharmacy
 
LC NMR HYPHENATED TECHNIQUES
LC NMR HYPHENATED TECHNIQUESLC NMR HYPHENATED TECHNIQUES
LC NMR HYPHENATED TECHNIQUESarulrathna
 
Modern Analytical System-Bioanalysis
Modern Analytical System-BioanalysisModern Analytical System-Bioanalysis
Modern Analytical System-Bioanalysismahathiviji
 

Similaire à HPLC (20)

HPLC instrument
HPLC instrumentHPLC instrument
HPLC instrument
 
Recent advancement in impurity profiling
Recent advancement in impurity profilingRecent advancement in impurity profiling
Recent advancement in impurity profiling
 
Prabhakar singh ii sem-paper v-hplc, fplc, uplc, rrlc
Prabhakar singh  ii sem-paper v-hplc, fplc, uplc, rrlcPrabhakar singh  ii sem-paper v-hplc, fplc, uplc, rrlc
Prabhakar singh ii sem-paper v-hplc, fplc, uplc, rrlc
 
Chromatography
ChromatographyChromatography
Chromatography
 
HPLC
HPLCHPLC
HPLC
 
Simultaneous estimation of uv spectroscopy and method development and validat...
Simultaneous estimation of uv spectroscopy and method development and validat...Simultaneous estimation of uv spectroscopy and method development and validat...
Simultaneous estimation of uv spectroscopy and method development and validat...
 
Shahid Ayoub.. HPTLC PPT
Shahid Ayoub.. HPTLC PPTShahid Ayoub.. HPTLC PPT
Shahid Ayoub.. HPTLC PPT
 
Hplc
Hplc Hplc
Hplc
 
Hplc
Hplc Hplc
Hplc
 
HPLC
HPLCHPLC
HPLC
 
عرض تحليل الي م3_095500.pptx
عرض تحليل الي م3_095500.pptxعرض تحليل الي م3_095500.pptx
عرض تحليل الي م3_095500.pptx
 
عرض تحليل الي م3_095500.pptx
عرض تحليل الي م3_095500.pptxعرض تحليل الي م3_095500.pptx
عرض تحليل الي م3_095500.pptx
 
Cromatografia líquida moderna
Cromatografia líquida modernaCromatografia líquida moderna
Cromatografia líquida moderna
 
High Performance Liquid Chromatography HPLC
High Performance Liquid Chromatography HPLCHigh Performance Liquid Chromatography HPLC
High Performance Liquid Chromatography HPLC
 
HPLC Presentation by moun
HPLC Presentation by mounHPLC Presentation by moun
HPLC Presentation by moun
 
HPLC (HIGH PERFORMANCE LIQUID CHROMATOGRAPHY)
HPLC (HIGH PERFORMANCE LIQUID CHROMATOGRAPHY)HPLC (HIGH PERFORMANCE LIQUID CHROMATOGRAPHY)
HPLC (HIGH PERFORMANCE LIQUID CHROMATOGRAPHY)
 
HPLC.pptx
HPLC.pptxHPLC.pptx
HPLC.pptx
 
ANALYTICAL.ppt
ANALYTICAL.pptANALYTICAL.ppt
ANALYTICAL.ppt
 
LC NMR HYPHENATED TECHNIQUES
LC NMR HYPHENATED TECHNIQUESLC NMR HYPHENATED TECHNIQUES
LC NMR HYPHENATED TECHNIQUES
 
Modern Analytical System-Bioanalysis
Modern Analytical System-BioanalysisModern Analytical System-Bioanalysis
Modern Analytical System-Bioanalysis
 

Dernier

How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17Celine George
 
Grade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptxGrade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptxChelloAnnAsuncion2
 
Barangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptxBarangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptxCarlos105
 
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)lakshayb543
 
Procuring digital preservation CAN be quick and painless with our new dynamic...
Procuring digital preservation CAN be quick and painless with our new dynamic...Procuring digital preservation CAN be quick and painless with our new dynamic...
Procuring digital preservation CAN be quick and painless with our new dynamic...Jisc
 
How to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPHow to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPCeline George
 
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSGRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSJoshuaGantuangco2
 
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Celine George
 
Gas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptxGas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptxDr.Ibrahim Hassaan
 
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdfInclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdfTechSoup
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxthorishapillay1
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptxmary850239
 
Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Mark Reed
 
Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Celine George
 
ACC 2024 Chronicles. Cardiology. Exam.pdf
ACC 2024 Chronicles. Cardiology. Exam.pdfACC 2024 Chronicles. Cardiology. Exam.pdf
ACC 2024 Chronicles. Cardiology. Exam.pdfSpandanaRallapalli
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatYousafMalik24
 
Science 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptxScience 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptxMaryGraceBautista27
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxHumphrey A Beña
 
Q4 English4 Week3 PPT Melcnmg-based.pptx
Q4 English4 Week3 PPT Melcnmg-based.pptxQ4 English4 Week3 PPT Melcnmg-based.pptx
Q4 English4 Week3 PPT Melcnmg-based.pptxnelietumpap1
 

Dernier (20)

How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17
 
Grade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptxGrade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptx
 
Barangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptxBarangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptx
 
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
 
Procuring digital preservation CAN be quick and painless with our new dynamic...
Procuring digital preservation CAN be quick and painless with our new dynamic...Procuring digital preservation CAN be quick and painless with our new dynamic...
Procuring digital preservation CAN be quick and painless with our new dynamic...
 
How to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPHow to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERP
 
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSGRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
 
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
 
Gas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptxGas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptx
 
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdfInclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptx
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx
 
Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)
 
Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17
 
ACC 2024 Chronicles. Cardiology. Exam.pdf
ACC 2024 Chronicles. Cardiology. Exam.pdfACC 2024 Chronicles. Cardiology. Exam.pdf
ACC 2024 Chronicles. Cardiology. Exam.pdf
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice great
 
Science 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptxScience 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptx
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
 
YOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptx
YOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptxYOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptx
YOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptx
 
Q4 English4 Week3 PPT Melcnmg-based.pptx
Q4 English4 Week3 PPT Melcnmg-based.pptxQ4 English4 Week3 PPT Melcnmg-based.pptx
Q4 English4 Week3 PPT Melcnmg-based.pptx
 

HPLC

  • 1. HPLC I/II, Ist Semester M.Pharmacy Dept . Of Pharmaceutical Analysis, JNTUH Lecture by: RAVI PRATAP PULLA M.Pharm., Ph.D Asso.Professor, SSJ College of Pharmacy, V.N.Pally, Gandipet, Hyderabad-75. SSJCP, Department of Pharmaceutical Analysis 1
  • 2. HPLC – THE DEVELOPMENT OF A NAME PERFORMANCE PRESSURE Price Prestige Peak Profit Propaganda High Promise Chromatography Philosophy Polite Problem Ph (F) antasy Liquid Pragmatic Pleasure Passion SSJCP, Department of Pharmaceutical Analysis 2
  • 3. Introduction to Liquid Chromatography Columns System Components Applications Troubleshooting SSJCP, Department of Pharmaceutical Analysis 3
  • 4. A Brief History of Chromatography  1903: Russian botanist Mikhail Tswett separated plant pigments  1938: Russian scientists Izmailov and Shraiber use “drop chromatography”.  Later perfected as Thin Layer Chromatography (TLC) by Kirchner in the U.S.  1952: Martin and Synge receive Nobel Prize for “invention of partition chromatography” or plate theory to describe column efficiency. SSJCP, Department of Pharmaceutical Analysis 4
  • 5.  1966: HPLC was first named by Horvath at Yale University but HPLC didn’t “catch on” until the 1970s  1978: W.C. Stills introduced “flash chromatography”, where solvent is forced through a packed column with positive pressure. SSJCP, Department of Pharmaceutical Analysis 5
  • 6. Modern HPLC  Late 1970s/early 1980s ►Instrumentation developed for high pressure solvent delivery: pumps, autosamplers, diode array detectors ► More uniform packing material produced columns for  Last 20 years ► Nothing really “new”, but by returning to the basic theory of chromatography, even better columns are on the market: smaller particle sizes which yield faster separations, but require hardware to withstand higher pressures. SSJCP, Department of Pharmaceutical Analysis 6
  • 7. What is Chromatography?  Separation of a mixture into individual components.  The separation uses a Column (stationary phase) and Solvent (mobile phase).  The components are separated from each other based on differences in affinity for the mobile or stationary phase.  The goal of the separation is to have the best RESOLUTION possible between components. SSJCP, Department of Pharmaceutical Analysis 7
  • 8. CHROMATOGRAPHY IS INCOMPLETE WITHOUT LEARNING FEW BASIC TERMINOLOGIES For any further clarification or details of the below content(s) feel free to mail me : ravipratappulla@gmail.com SSJCP, Department of Pharmaceutical Analysis 8
  • 9. Absorption Bonded phase Additive Breakthrough volume Adsorbent Capillary column Adsorption Capillary LC Adsorption isotherm Cartridge column Affinity chromatography Cation exchange chromatography Agarose Channeling Alumina Chemisorption Amphoteric ion-exchange phase Chiral stationary phase Analyte Chlorosilane Anion exchange chromatography Co-ion Bed volume Column back pressure BET (Brunauer, Emmet & Teller) Column chromatography method SSJCP, Department of Pharmaceutical Analysis
  • 10. Column plate number Eluite Column switching Elute Column volume Elution Competing base Exclusion chromatography (Size) Counterion Extra column effects Coverage Fast protein LC (FPLC) Cross-links Frontal chromatography Dead time (to / tm ) Displacement chromatography Gel filtration chromatography (GFC) Gradient elution Dynamic coating Graphitized carbon packing Effluent Guard column Eluate Heart cutting Eluent Hold-up volume ( VM or tM ) Degassing SSJCP, Department of Pharmaceutical Analysis
  • 11. Hydrophobic interaction chromatography (HIC) Ion exclusion Ion chromatography Ion moderated partioning chromatography (IMPC) Imprinted phases Ion pair chromatography (IPC) Indirect detection Linear chromatography Injector (sample) Linear velocity Inlet Liquid chromatography In-line filter Mobile phase velocity Interparticle porosity (ee) Open tubular column Interstitial volume Partition chromatography Intraparticle porosity (ei) Packed column Intraparticle volume Peak Ion exchange chromatography Peak area Ion chromatography (IC) Peak maximum SSJCP, Department of Pharmaceutical Analysis 11
  • 12. Peak width Retention factor (k) Phase ratio Retention volume (VR or tR) Plate height (H) Separation factor (a) Plate number (N) Solid support Pressure drop Solute Reduced mobile phase velocity (n) Stationary phase Resolution (Peak) [ Rs ]/ Resolution(R) Tailing Reduced plate height (h) Void volume Relative Retention time (RRT) Retention time (tR ) Interparticle time (tZ) Capacity factor (k’) Dead Volume(Vd) Selectivity factor (α) SSJCP, Department of Pharmaceutical Analysis 12
  • 13. Activity Adsorption chromatography Asymmetry Back pressure Back flushing Band spacing Baseline Baseline noise Baseline resolved peak Breakthrough volume Buffer Calibration standard Capacity factor Chain length Channeling Chromatogram Chromatographic conditions Chromatographic resolution Chromatographic system Column performance Dead volume (Vm) Dead time (tm) Detection Detector Detection threshold Detector linearity SSJCP, Department of Pharmaceutical Analysis 13
  • 14. Detector sensitivity Differential Refractive Index( RI) Electrochemical detector Elution order Elution chromatography Eluotropic sequence Elution volume Extra column volume External standard Flow rate Fluorescence detector Frit Fronting HETP Hydrophilic Hydrophobic Internal standard Integrator Interstitial particle volume Ion exchanger Ion suppression Isocratic analysis Isothermal chromatography Ligand Loading matrix SSJCP, Department of Pharmaceutical Analysis 14
  • 15. Organic modifier Overload Partially resolved peaks Particle size (medium) Particle size distribution Peak broadening Peak area Peak base Peak height Peak identification Peak Quantitation Peak shape Phase system Polarity Pore diameter Pore volume Post column derivatization Pre column Pulsating flow Recycling Regeneration Retention Retention time Retention volume Sample Sample capacity SSJCP, Department of Pharmaceutical Analysis 15
  • 16. Sample preparation Separation capacity silanization Silanol groups Sorbent S.P chemically bonded S.P Surface modification Specific surface SFC( supercritical fluid chromatography) Vacancy chromatogram Void Void time SSJCP, Department of Pharmaceutical Analysis 16
  • 17. IUPAC RECOMMENDATIONS & FREQUENTLY USED SYMBOLS IN PARAMETER SYMBOL CHROMATOGRAPHY α Separation factor Selectivity factor (up to 1993 A.D) Area α a/A Diameter de Diffusion coefficient d ε / εt Porosity Flow rate (volumetric) f Plate height h Viscosity η Equilibrium distribution constant k Rate constant k Retention factor k SSJCP, Department of Pharmaceutical Analysis 17
  • 18. PARAMETER Capacity factor SYMBOL k’ Length of the column l / L Plate number /number of theoretical plates n / N Density ρ Pressure p / P Pressure (relative) p Radius r Temperature (absolute) Time t /T t Retention time tr / tR Velocity (linear) u Volume v SSJCP, Department of Pharmaceutical Analysis 18
  • 19. PARAMETER SYMBOL Retention volume vr Mass (Weight) w Peak width w Difference ∆ Partial diameter dp Flow F Height equivalent of a theoretical plate(HETP) H Internal diameter of the column I.D Wavelength λ Iso electric point pKa Resolution R Death time tm / t0 SSJCP, Department of Pharmaceutical Analysis 19
  • 20. PARAMETER SYMBOL Gradient time tG Net retention time tR' Linear velocity μ Dead volume of apparatus Vd Pore volume Vp For any further clarification or details of the above content(s) feel free to mail me : ravipratappulla@gmail.com SSJCP, Department of Pharmaceutical Analysis 20
  • 21. The Most Basic Explanation of Chromatography Ever SSJCP, Department of Pharmaceutical Analysis 21
  • 22.  Drugs in multi component dosage forms, analyzed by HPLC method because of the several advantages like:  Improved resolution of the separated substances  Faster separation times  The improved accuracy, precision, & sensitivity with which the separated substances may be quantified. SSJCP, Department of Pharmaceutical Analysis 22
  • 23. How Do You Get Separation?  Hardware: pumps, injector, detector  Column: particle diameter, column size, packing materials  Our seminar will focus on the contribution of each factor to perform separations. SSJCP, Department of Pharmaceutical Analysis 23
  • 24.  Column Considerations ► Theory (including, well...you know) ► Different Stationary Phases  Hardware Components ► Pumps, Injectors, Detectors, etc. ► Examples of Application-Specific Configurations  Applications ► Pharmaceuticals and Proteomics ► Food and Beverage, Environmental ► Research and Method Development SSJCP, Department of Pharmaceutical Analysis 24
  • 25.  System Troubleshooting Leaks, Reproducibility, Column Care, and More  Chromatography Software Method and Sequence Setup Calibration Curves and Reporting  Chromatography Hardware Modular LC-20 Prominence Integrated LC-2010HT, Empower 2 SSJCP, Department of Pharmaceutical Analysis 25
  • 26. Modern HPLC v/s Traditional LC Methods  Classical open-column LC.  Thin-Layer Chromatography (TLC) and paper chromatography.  In modern HPLC the columns and packings are, in general, highly refined, high in resolving capacity, and are reusable. SSJCP, Department of Pharmaceutical Analysis 26
  • 27. HPLC and Pre-HPLC Techniques SSJCP, Department of Pharmaceutical Analysis 27
  • 28. MODES OF SEPARATION IN HPLC  There are different modes of separation in HPLC: ►Normal phase mode ► Reversed phase mode ► RP - Ion pair chromatography ► Affinity/Bioaffinity chromatography ► Size exclusion chromatography ► Displacement chromatography SSJCP, Department of Pharmaceutical Analysis 28
  • 29.  Based on mode of chromatography ► Normal phase mode ► Reverse phase mode  Based on principle of separation ► Adsorption chromatography ► Ion exchange chromatography ► Ion pair chromatography ► Size exclusion chromatography ► Affinity chromatography SSJCP, Department of Pharmaceutical Analysis 29
  • 30.  Based on elution technique ► Isocratic separation ► Gradient separation  Based on the scale of operation ► Analytical HPLC ► Preparative HPLC  Based on the type of analysis ► Qualitative analysis ► Quantitative analysis SSJCP, Department of Pharmaceutical Analysis 30
  • 31. COLUMN TYPES Normal Phase LC  Polar - stationary phase: Silica  Nonpolar - mobile phase: Hexane, Ethyl acetate  The LEAST polar compound comes out first  Generally used for separation of non polar compounds. SSJCP, Department of Pharmaceutical Analysis 31
  • 32. Normal Phase HPLC Columns Cyano : `Rugged, moderate polarity, general use -OH (Diol) : More polar and retentive Amino : Highly polar, less stable Silica : Very rugged, low cost, adsorbent & Unbonded NOTE: The cyano column with a low polarity mobile phase (hydrocarbon with a small amount of another solvent) will act as a normal phase column. SSJCP, Department of Pharmaceutical Analysis 32
  • 33.  this method separates analytes based on their affinity for a polar stationary surface such as silica  based on analyte ability to engage in polar interactions (such as hydrogen-bonding or dipole-dipole type of interactions) with the sorbent surface.  Adsorption strengths increase with increased analyte polarity  interaction strength depends on the functional groups present in the structure of the analyte molecule, but also on steric factors SSJCP, Department of Pharmaceutical Analysis 33
  • 34.  more polar solvents in the mobile phase will decrease the retention time of analytes  hydrophobic solvents tend to induce slower elution (increased retention times)  traces of water in the mobile phase tend to adsorb to the solid surface of the stationary phase forming a stationary bound (water) layer which is considered to play an active role in retention.   governed mechanism almost exclusively by an SSJCP, Department of Pharmaceutical Analysis adsorptive 34
  • 35. Reversed-Phase LC  Nonpolar - stationary phase: C8, C18  Polar - mobile phase: Water, ACN, Methanol  The MOST polar compound comes out first  Generally used for separation of polar compounds SSJCP, Department of Pharmaceutical Analysis 35
  • 36. C18, C8 RP-HPLC Columns : Rugged, general purpose, highly retentive C3, C4 : Less retentive, used mostly for peptides & proteins Phenyl : Greater selectivity than alkyl-bonded Cyano : Moderate retention, normal & rev. phase Amino : Weak retention, good for carbohydrates NOTE : The cyano column with a high polarity mobile phase (Water/MeOH) will act as a RP- Column. SSJCP, Department of Pharmaceutical Analysis 36
  • 37.  stationary phase is a silica which has been surfacemodified with RMe2SiCl, where R is a straight chain alkyl group such as C18H37 or C8H17.  retention time is longer for molecules which are less polar, while polar molecules elute more readily   can increase retention times by adding more water to the mobile phase  the affinity of the hydrophobic analyte for the hydrophobic stationary phase stronger relative to the now more hydrophilic mobile phase SSJCP, Department of Pharmaceutical Analysis 37
  • 38.  decrease retention time by adding more organic solvent to the eluent  RP-HPLC operates on the principle of hydrophobic interactions  RP-HPLC allows the measurement of these interactive forces.   The binding of the analyte to the stationary phase is proportional to the contact surface area around the nonpolar segment of the analyte molecule upon association with the ligand on the stationary phase. SSJCP, Department of Pharmaceutical Analysis 38
  • 39.  solvophobic effect is dominated by the force of water for "cavity-reduction" around the analyte and the C18-chain versus the complex of both.  The retention can be decreased by adding a less polar solvent (methanol, acetonitrile) into the mobile phase to reduce the surface tension of water.   Gradient elution uses this effect by automatically reducing the polarity and the surface tension of the aqueous mobile phase during the course of the analysis.  Structural properties of the analyte molecule play an important role in its retention characteristics. SSJCP, Department of Pharmaceutical Analysis 39
  • 40.  an analyte with a larger hydrophobic surface area (C-H, C-C, and generally non-polar atomic bonds, such as S-S and others) is retained longer because it is non-interacting with the water structure.  analytes with higher polar surface area (conferred by the presence of polar groups, such as -OH, -NH2, COO– or -NH3+ in their structure) are less retained as they are better integrated into water.  interactions are subject to steric effects in that very large molecules may have only restricted access to the pores of the stationary phase, where the interactions with surface ligands (alkyl chains) take place. SSJCP, Department of Pharmaceutical Analysis 40
  • 41.  surface hindrance typically results in less retention.  Retention time increases with hydrophobic (non-polar) surface area.  Branched chain compounds elute more rapidly than their corresponding linear isomers because the overall surface area is decreased.  organic compounds with single C-C-bonds elute later than those with a C=C or C-C-triple bond, as the double or triple bond is shorter than a single C-C-bond. SSJCP, Department of Pharmaceutical Analysis 41
  • 42.  mobile phase surface tension (organizational strength in eluent structure), other mobile phase modifiers can affect analyte retention.  entropy of the analyte-solvent interface is controlled by surface tension, the addition of salts tend to increase the retention time.  mobile phase pH can change the hydrophobic character of the analyte.  For this reason most methods use a buffering agent, such as sodium phosphate, to control the pH.  SSJCP, Department of Pharmaceutical Analysis 42
  • 43.  Ammonium formate is commonly added in mass spectrometry to improve detection of certain analytes by the formation of analyte-ammonium adducts.  volatile organic acid such as acetic acid, or formic acid, is often added to the mobile phase if mass spectrometry is used to analyze the column effluent.  Trifluoroacetic acid is used infrequently in mass spectrometry applications due to its persistence in the detector and solvent delivery system, but can be effective in improving retention of analytes such as carboxylic acids in applications utilizing other detectors, as it is a fairly strong organic acid.  SSJCP, Department of Pharmaceutical Analysis 43
  • 44.  Reversed phase columns consist of alkyl derivatized silica particles and should never be used with aqueous bases as these will destroy the underlying silica particle.  Can be used with aqueous acid, but the column should not be exposed to the acid for too long, as it can corrode the metal parts of the HPLC equipment.  A good test for the metal content of a column is to inject a sample which is a mixture of 2,2'- and 4,4'- bipyridine.  Because the 2,2'-bipy can chelate the metal, the shape of the peak for the 2,2'-bipy will be distorted (tailed) when metal ions are present on the surface of the silica. SSJCP, Department of Pharmaceutical Analysis 44
  • 45. TYPICAL COLUMN SIZES SSJCP, Department of Pharmaceutical Analysis 45
  • 46. SSJCP, Department of Pharmaceutical Analysis 46
  • 47.  Particle size: 5 µm, 3 µm, and smaller  Mono dispersed means particles are the same size  Very important for stable pressure and flow  Smaller particles produce higher system pressure ► Pore size: 100-120 A is typical ► Surface area: 300-350 m2/g ► Carbon load: 9-12% for C8, 16-20% for C18  Higher carbon load = better resolution but longer run times  Lower carbon load = shorter run times, but may change selectivity v/s higher carbon load SSJCP, Department of Pharmaceutical Analysis 47
  • 48. RP-HPLC MECHANISM      Synthesis of RP Packing RP Column Properties RP Retention Mechanisms Important RP parameters RP Optimization SSJCP, Department of Pharmaceutical Analysis 48
  • 49. Synthesis of RP Packing SSJCP, Department of Pharmaceutical Analysis 49
  • 50. RP COLUMN PREPARATION SSJCP, Department of Pharmaceutical Analysis 50
  • 51. COMMON RP PACKING SSJCP, Department of Pharmaceutical Analysis 51
  • 52. RP COLUMN PROPERTIES ► Hydrophobic Surface ► Particle Size and Shape ► Particle Size Distribution ► Porosity, Pore Size and Surface Area SSJCP, Department of Pharmaceutical Analysis 52
  • 53. PARTICLE SIZE ► Columns have a distribution of particle sizes ► Reported “particle diameter” is an average ► Broader distribution ---> broader peaks SSJCP, Department of Pharmaceutical Analysis 53
  • 54. Particle Size Distribution of several column batches Copyrights: Neue, HPLC Columns Theory, Technology and Practice, Wiley, 1997, p.82 SSJCP, Department of Pharmaceutical Analysis 54
  • 55. RP MECHANISM (SIMPLE) SSJCP, Department of Pharmaceutical Analysis 55
  • 56. RP Mechanism (Advanced)  Classical measures of retention ► capacity factors ► partition coefficients ► Van’t Hoff Plots  Give bulk properties only ► do not give molecular view of separation process SSJCP, Department of Pharmaceutical Analysis 56
  • 57. PROPOSED RP MECHANISMS ► Hydrophobic Theory ► Partition Theory ► Adsorption Theory SSJCP, Department of Pharmaceutical Analysis 57
  • 58. HYDROPHOBIC THEORY  Chromatography of “cavities” in solvent created by hydrophobic portion of analyte molecule  Surface Tension  Interaction of polar functions with solvent  Stationary phase is passive SSJCP, Department of Pharmaceutical Analysis 58
  • 59. PARTITION THEORY  Analyte distributes between aqueous mobile phase and organic stationary phase  Correlation between log P and retention “organic” phase is attached on one end  Does not explain shape selectivity effects SSJCP, Department of Pharmaceutical Analysis 59
  • 60. ADSORPTION THEORY  Analytes “land” on surface - do not penetrate  Non-polar interactions between analyte hydrophobic portion and bonded phase  Weak interactions ► dipole-dipole ► dipole-induced dipole ► induced dipole-induced dipole SSJCP, Department of Pharmaceutical Analysis 60
  • 61. None of the above can completely explain all of the observed retention in RP-HPLC SSJCP, Department of Pharmaceutical Analysis 61
  • 62. IMPORTANT REVERSED PHASE PARAMETERS  Solvent (mobile phase ) Strength  Choice of Solvent  Mobile Phase pH  Silanol Activity SSJCP, Department of Pharmaceutical Analysis 62
  • 63. SOLVENT STRENGTH  Water is “weak” solvent  Increased organic ---> decreased retention  Organic must be miscible with water SSJCP, Department of Pharmaceutical Analysis 63
  • 64. EFFECT OF SOLVENT SSJCP, Department of Pharmaceutical Analysis 64
  • 65. SOLVENT STRENGTH COPYRIGHTS:Snyder and Kirkland, Introduction to Modern Liquid Chromatography, Wiley, 1979, p. 286. SSJCP, Department of Pharmaceutical Analysis 65
  • 66. VARYING SELECTIVITY 30% MeCN 45% MeOH 70% Water 55% Water 30x0.46 cm C-18, 1.5 mL.min,254 nm, 10 mg each COPYRIGHTS:Snyder and Kirkland, introduction to Modern Liquid Chromatography, Wiley, 1979, p. 287. SSJCP, Department of Pharmaceutical Analysis 66
  • 67. pH  Affects ionizable compounds ► organic acids ► organic bases  In reversed phase we need to suppress ionization as much as possible  May need very precise pH control SSJCP, Department of Pharmaceutical Analysis 67
  • 68. pH Effect on Retention 1. Salicylic acid 2. Phenobarbitone 3. Phenacetin 4. Nicotine 5. Methylampohetamine 30x0.4 cm C-18, 10 mm, 2 mL/min, UV 220 nm COPYRIGHTS: Snyder and Kirkland, Introduction to Modern Liquid Chromatography, Wiley, 1979, p. 288. SSJCP, Department of Pharmaceutical Analysis 68
  • 69. Use of Buffers  0.1 pH unit ---> significant effect on retention  Buffer mobile phase for pH reproducibility  pH of buffer should be within 1 pH unit of pKa of acid (best at pH = pKa)  Buffers weak (100 mM or less)  Check solubility SSJCP, Department of Pharmaceutical Analysis 69
  • 70. Common buffers Buffer pKa Values Phosphate 2, 7 Acetate 4.75 Citrate 3.08, 4.77, 6.40 Useful buffering between pH 2-8. SSJCP, Department of Pharmaceutical Analysis 70
  • 71. Silanol Activity  RP ligands occupy about 50% of silanols  Others are “active”  Weak acids SSJCP, Department of Pharmaceutical Analysis 71
  • 72. Silica Surface SSJCP, Department of Pharmaceutical Analysis 72
  • 73. Dealing with Residual Silanols  Silanols cause peak tailing and excessive retention  Endcapping ► bond a smaller group (helps a little)  Pre-treatment of silica ► fully hydroxylated best ► high purity best SSJCP, Department of Pharmaceutical Analysis 73
  • 74. Silanol Interactions  Hydrogen bonding  Dipole-dipole  Ion exchange  Low pH --> silanols protonated  Add basic modifier (TEA) to compete for sties SSJCP, Department of Pharmaceutical Analysis 74
  • 75. pH Effect on Tailing Neue, p196 SSJCP, Department of Pharmaceutical Analysis
  • 76. RP Optimization SSJCP, Department of Pharmaceutical Analysis 76
  • 77. SSJCP, Department of Pharmaceutical Analysis 77
  • 78. IDEALIZED HPLC SEPARATION SSJCP, Department of Pharmaceutical Analysis 78
  • 79. VOID VOLUME  The void volume is the amount of “dead” volume in the column that is not taken up by the particles of stationary phase.  In general, there is approximately 0.1 mL of void volume for each cm of column length, for columns with a 4.6 mm i.d. and 5 µm particles Vm ≈ 0.5dc2L Where, Vm is the column volume in mL, L is the column length in cm, and dc is the inner diameter in cm SSJCP, Department of Pharmaceutical Analysis 79
  • 80.  The void volume is exactly determined by injecting a compound that is completely unretained, then using the chromatogram to calculate void volume.  void volume = Elution time x flow rate SSJCP, Department of Pharmaceutical Analysis 80
  • 81. FACTORS INFLUENCING RESOLUTION  Capacity Factor, k’  Selectivity Factor, α  Efficiency, N SSJCP, Department of Pharmaceutical Analysis 81
  • 82. RESOLUTION  For closely eluting or adjacent peaks, the resolution equation may be expressed as: Rs = 1 / 4[(α − 1) / α ] N [k ' /(1 + k ' )]  The terms of capacity factor (k’), selectivity (α), and efficiency (N) all contribute to resolution SSJCP, Department of Pharmaceutical Analysis 82
  • 83. THE RESOLUTION EQUATION  Resolution is defined as the completeness of separation from one analyte to another  In general, resolution may be expressed as: Rs = 2(Vrb - Vra)/(Wa + Wb) = 2(trb - tra)/ (Wa + Wb) Where, Vra/b = retention volume of peak a/b t a/b = retention time of peak a/b SSJCP, rDepartment of Pharmaceutical Analysis 83
  • 84. CAPACITY FACTOR, k ’  The relative degree to which an analyte component is delayed as it is eluted through a given system (retentivity). k’ = (V r - V 0 )/V 0 = (t r - t 0 )/t 0 Where, Vr = peak retention volume V0 = column void volume tr = peak retention time t0 = peak void time  The larger the k’, the later the analyte elutes after the void. SSJCP, Department of Pharmaceutical Analysis 84
  • 85. EFFECT OF k’ ON OVERALL RESOLUTION  As k’ grows larger, its effect reaches a limit at a value of about 10.  Since k’ depends on retention time, longer columns eventually have a diminished effect on resolution. SSJCP, Department of Pharmaceutical Analysis 85
  • 86. INFLUENCING THE CAPACITY FACTOR (k’)  Retentivity (k’) decreases 2 - 3 fold for each 10% increase in mobile phase strength.  Which of these is easiest to change?? ► Mobile Phase Strength As per the rule of thumb, altering the mobile phase strength also alters the retention of the analytes. ► Bonded Phase Functionality (RP) As the bonded phase hydrophobicity increases (increasing alkyl chain length, etc.) so will the retention of the analytes. ► Temperature As temperature increases, the retention time decreases. This does not necessarily result in poorer separation because of the other factors in the resolution equation. SSJCP, Department of Pharmaceutical Analysis 86
  • 87. Mobile Phase Strength v/s k 4.6 mm ID Column, 1 mL/min, Changing MeOH % vs Water 0.079 100% 100% 90% 90% ’ Capacity Factor for Butyl Paraben (Peak 4) 0.212 0.472 80% 80% 70% 70% 1.127 2.813 60% 60% 7.666 50% 50% SSJCP, Department of Pharmaceutical Analysis 87
  • 88. Temperature Effect on k 50°C ’ 2.1 mm ID Column, 0.35 mL/min, 50/50 MeOH/Water 45°C 40°C 35°C 30°C 25°C 20°C SSJCP, Department of Pharmaceutical Analysis 88
  • 89. Summary of k Effects ’  A larger value of k’ means better resolution...to a certain extent (k’ = 10 maximum)  Increasing the mobile phase strength decreases k’  Increasing the temperature decreases k’, but may not result in a “bad” separation based on the other factors affecting resolution. SSJCP, Department of Pharmaceutical Analysis 89
  • 90. Selectivity Factor, α  The selectivity or separation factor represents the ratio of any two adjacent k’ values, there by describing the relative separation of adjacent peaks.  This relationship is expressed as: α = k’b/k’a  If α = 1, two components are perfectly overlapping  For early eluting peaks you want α to be large for good resolution.  For later eluting peaks, α can be smaller and still have acceptable separation. SSJCP, Department of Pharmaceutical Analysis 90
  • 91. Effect of α on Overall Resolution  Remember the resolution equation? Rs = 1 / 4[(α − 1) / α ] N [k ' /(1 + k ' )]  Let’s only look at the part involving α Rs = 1 / 4[(α −1) / α]  And see how much resolution will improve with small changes in α SSJCP, Department of Pharmaceutical Analysis 91
  • 92.  For an α value of 1.1, the contribution of the selectivity term is (1.1 – 1) / 1.1 = 0.09  For an α value of 1.4, the contribution of the selectivity term is (1.4 – 1) / 1.4 = 0.29  So, a very small change in α leads to a more than THREE-FOLD increase in the contribution to resolution. SSJCP, Department of Pharmaceutical Analysis 92
  • 93.  As α grows larger, its effect reaches a limit at a value of about 5.  Since α depends on components’ retention factor k’, longer columns eventually have a diminished effect on resolution. SSJCP, Department of Pharmaceutical Analysis 93
  • 94. Influencing the Selectivity Factor α  Which of these is easiest to change?? ► Mobile Phase Type The importance of the type of interactions between the mobile phase and analytes is critical to the optimization of the selectivity of a system. ► Column Type The bonded phase functionality can be selected by its chemical nature to provide better selectivity in an analytical method. ► Temperature Selective interactions between analyte molecules and the stationary phase may not become evident until a critical temperature is attained. SSJCP, Department of Pharmaceutical Analysis 94
  • 95. Summary of α Effects  Since α is the ratio of two k’ values, the same general statements apply: ► Increasing the mobile phase strength decreases individual values of k’, but their ratio (α) may affect resolution ► Increasing the temperature decreases individual values of k’, but their ratio (α) may significantly affect resolution.  A small increase in α leads to a large increase in resolution SSJCP, Department of Pharmaceutical Analysis 95
  • 96. Column Efficiency, N  The column efficiency is defined as the degree to which a column and/or other system components can physically and chemically affect the separation of analytes.  As column efficiency increases, analyte components will elute in a smaller volume of the mobile phase, usually observed as narrower or “sharper” peak shapes.  Column efficiency is generally expressed in terms of theoretical plate number. SSJCP, Department of Pharmaceutical Analysis 96
  • 97. Calculation of Theoretical Plates N = A(tr /W)2 W A 4 Wh 5.54 Wi Method Width measured at Inflection point (60.7% of peak height) ½ Height 50% of peak height W3s 3s 32.4% of peak height W4s 16 4s 13.4% of peak height W5s 25 Wb 9 5s 4.4% of peak height 16 Tangent Baseline, following tangent drawing Constants A are different at each peak width, assuming a perfect Gaussian shape. Real-world peaks often have tailing, so widths measured at the lower part of the peak more accurately reflect the tailing when calculating N. SSJCP, Department of Pharmaceutical Analysis 97
  • 98. Calculation of Efficiency, N Width measured at the baseline after tangent lines are drawn on the peak. Used when tailing is minimal. Width measured at 4.4% of peak height, no tangents drawn. Used when tailing is significant. SSJCP, Department of Pharmaceutical Analysis 98
  • 99. Effect of N on Overall Resolution  Do you STILL remember the resolution equation? Rs let’s/lookαat − 1)part ]involving/(1 + k ' )] = 1 4[( the / α N [k ' N  Now Rs = 1 / 4 N  And see how much resolution will improve with changes in N SSJCP, Department of Pharmaceutical Analysis 99
  • 100.  Since the contribution of N to resolution is a square root, doubling N from 5000 to 10,000 only increases the contribution to resolution by 41%.  To double the effect on resolution coming from N, we have to increase the value of N by a factor of 4 PLATE Plates 5000 5,000 10,000 10,000 20,000 20,000 √N CONTRIBUTION 141.4 100% √N Contribution 70.7 70.7 - - - - ----100 100 41% 41% 141.4 100% SSJCP, Department of Pharmaceutical Analysis 100
  • 101. Effect of N on Overall Resolution  Note that there is no flattening of the curve like with k ’ and α.  Resolution will continue to increase as theoretical plates increase. SSJCP, Department of Pharmaceutical Analysis 101
  • 102. Influencing the Efficiency, N  Particle Size and Size Distribution The smaller the particle size and the narrower the range of the particle size distribution, the more efficient the column.  Packing Type Totally porous particles will also have greater efficiency than solid or pellicular-shaped packing's, due to the additional surface area attributable to the pores.  Mobile Phase Viscosity As mobile phase viscosity increases, molecular movement through the mobile phase is inhibited.  Temperature For reverse phase chromatography, an increase in efficiency, N, may be realized as column temperature is increased. SSJCP, Department of Pharmaceutical Analysis 102
  • 103. Effect of Particle Size on N  Smaller particle sizes result in higher numbers of theoretical plates Column Diameter (mm) Column Length (cm) Particle Size (µm) 4σ Peak Width (µL) Theoretical Plates per centimeter 10 25 10 1118 333 4.6 25 10 237 333 4.6 25 5 167 667 4.6 10 5 106 667 4.6 10 3 82 1111 4.6 3 3 45 1111 3 10 5 45 667 2 25 10 45 333 2 25 5 32 667 2 10 5 20 667 2 10 3 15 1111 1 25 10 11 333 1 25 5 8 667 1 25 3 6 1111 1 10 5 5 667 1 10 3 4 1111 SSJCP, Department of Pharmaceutical Analysis 103
  • 104. Relative Influence of All Factors on Resolution Parameter Change N k’ α Rs Standard +10% N -25% N -50% N -60% N -75% N +10% k’ +10% α 10,000 11,000 7,500 5,000 4,000 2,500 10,000 10,000 2 2 2 2 2 2 2.2 2 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.2 1.52 1.59 1.31 1.07 0.96 0.76 1.56 2.78 Note that changing α a very small amount has the biggest effect SSJCP, Department of Pharmaceutical Analysis 104
  • 105. Review of Factors PARAMTER INFLUENCED BY TARGET VALUE Efficiency, N Column, system flow path, configuration Minimum of 400 theoretical plates /cm Capacity factor, k’ MP strength 1.0 - 10 Selectivity, α M.P & S.P type 1.1 - 2 All of the above 1.3 – 1.5 or greater Resolution, Rs SSJCP, Department of Pharmaceutical Analysis 105
  • 106. Normal Phase v/s Reversed Phase PARAMETER NP RP Polarity of packing Medium to high Low to medium Polarity of solvent Low to medium Medium to high Elution sequence Low polarity first High polarity first Increase solvent polarity Faster elution Slower elution SSJCP, Department of Pharmaceutical Analysis 106
  • 107. ION EXCHANGE CHROMATOGRAPHY SSJCP, Department of Pharmaceutical Analysis 107
  • 108.  based on the attraction between solute ions and charged sites bound to the stationary phase.  The stationary phase contains ionic groups like NR⁺з, SO⁻з which interact with the ionic groups of the sample molecules.  This method is suitable for the separation of charged molecules only.  Solute ions of the same charge as the charged sites on the column are excluded from binding  solute ions of the opposite charge of the charged sites of the column are retained on the column.  Strong acids & basic compounds may be separated by RP mode by forming ion pairs with suitable counter ions. SSJCP, Department of Pharmaceutical Analysis 108
  • 109.  Solute ions that are retained on the column can be eluted from the column by changing the solvent conditions  They include: ► increasing the ion effect of the solvent system ► by increasing the salt concentration of the solution ► increasing the column temperature ► changing the pH of the solvent  SSJCP, Department of Pharmaceutical Analysis 109
  • 110.  ion exchangers favor the binding of ions of higher charge and smaller radius.  increase in counter ion (with respect to the functional groups in resins) concentration reduces the retention time.  decrease in pH reduces the retention time in cation exchange while an increase in pH reduces the retention time in anion exchange.   lowering the pH of the solvent in a cation exchange column, more hydrogen ions are available to compete for positions on the anionic stationary phase, thereby eluting weakly bound cations. SSJCP, Department of Pharmaceutical Analysis 110
  • 111. TYPES OF ION EXCHANGERS  Polystyrene resins ►These allow cross linkage which increases the stability of the chain. ►Higher cross linkage reduces swerving, which increases the equilibration time and ultimately improves selectivity.  Cellulose and dextran ion exchangers (gels) ► These possess larger pore sizes and low charge densities making them suitable for protein separation.  Controlled-pore glass or porous silica SSJCP, Department of Pharmaceutical Analysis 111
  • 112. Examples  Stationary phase contains charged groups  SAX (Strong Anion Exchange): NH3+  WAX (Weak Anion Exchange): NR2H+(DEAE) [Di Ethyl Amino Ethanol]  SCX (Strong Cation Exchange): SO3-  WCX (Weak Cation Exchange): CarboxyMethyl (CM)  More highly charged analytes have stronger retention  More “bulky” stationary phases have weaker retention SSJCP, Department of Pharmaceutical Analysis 112
  • 113.  IEC is widely used in the following applications: ►water purification ► preconcentration of trace components ► ligand-exchange chromatography ► ion-exchange chromatography of proteins ► high-pH anion-exchange chromatography of carbohydrates and oligosaccharides SSJCP, Department of Pharmaceutical Analysis 113
  • 114. AFFINITY/ BIOAFFINITY CHROMATOGRAPHY SSJCP, Department of Pharmaceutical Analysis 114
  • 115. AFFINITY CHROMATOGRAPHY  It uses highly specific biochemical interactions for separations.  The stationary phase contains specific groups of molecules which can absorb the sample if certain steric & charge related conditions are satisfied.  This technique can be used to isolate proteins, enzymes, receptors , ligands as well as antibodies from complex mixture. SSJCP, Department of Pharmaceutical Analysis 115
  • 116. Affinity chromatography can be used to:  Purify and concentrate a substance from a mixture into a buffering solution  Reduce the amount of a substance in a mixture  Discern what biological compounds bind to a particular substance  Purify and concentrate an enzyme solution. SSJCP, Department of Pharmaceutical Analysis 116
  • 117. Size Exclusion LC (or) Gel Permeation (or) Gel filtration SSJCP, Department of Pharmaceutical Analysis 117
  • 118.  Stationary phase is a polymer (polystyrene-divinyl benzene or acrylamide) with a defined pore size  Large compounds cannot fit into the pores and elute first  Used to determine molecular weight distribution of polymers  Separates molecules according to their molecular mass.  Largest molecules are eluted first and smaller molecules last.  useful for determining the tertiary structure andquaternary structure of purified proteins.  used primarily for the analysis of large molecules such as proteins or polymers.  SEC works by trapping these smaller molecules in the pores of a particle.   widely used for the molecular weight determination of polysaccharides. SSJCP, Department of Pharmaceutical Analysis 118
  • 119.  larger molecules simply pass by the pores as they are too large to enter the pores.  Larger molecules therefore flow through the column quicker than smaller molecules, that is, the smaller the molecule, the longer the retention time.  separates particles on the basis of molecular size (actually by a particle's Stokes radius or Stokes-Einstein radius, or hydrodynamic radius (RH).  named after George Gabriel Stokes is the radius of a hard sphere that diffuses at the same rate as the molecule.  generally a low resolution chromatography and thus it is often reserved for the final, "polishing" step of the purification. SSJCP, Department of Pharmaceutical Analysis
  • 120.  The main application of gel-filtration chromatography: ► fractionation of proteins and other water-soluble polymers ► while gel permeation chromatography is used to analyze the molecular weight distribution of organicsoluble polymers. ► Either technique should not be confused with gel electrophoresis, where an electric field is used to "pull" or "push" molecules through the gel depending on their electrical charges. SSJCP, Department of Pharmaceutical Analysis 120
  • 121. DISPLACEMENT CHROMATOGRAPHY  A molecule with a high affinity for the chromatography matrix (the displacer) will compete effectively for binding sites, and thus displace all molecules with lesser affinities  displacement chromatography has advantages over elution chromatography in that components are resolved into consecutive zones of pure substances rather than “peaks”.   because the process takes advantage of the nonlinearity of the isotherms, a larger column feed can be separated on a given column with the purified components recovered at significantly higher concentration. SSJCP, Department of Pharmaceutical Analysis 121
  • 122. Aqueous Normal-Phase Chromatography (ANP)  ANP is a chromatographic technique which encompasses the mobile phase region between RPC and organic normal phase chromatography (ONPC).  This technique is used to achieve unique selectivity for hydrophilic compounds, showing normal phase elution using reversed-phase solvents. SSJCP, Department of Pharmaceutical Analysis 122
  • 123. ISOCRATIC & GRADIENT ELUTION  A separation in which the mobile phase composition remains constant throughout the procedure is termed isocratic (constant composition).  Word was coined by Csaba Horvath  A separation in which the mobile phase composition is changed during the separation process is described as a gradient elution  In isocratic elution, peak width increases with retention time linearly   leads to the disadvantage that late-eluting peaks get very flat and broad.  SSJCP, Department of Pharmaceutical Analysis 123
  • 124.  Gradient elution decreases the retention of the latereluting components so that they elute faster, giving narrower (and taller) peaks for most components  improves the peak shape for tailed peaks, as the increasing concentration of the organic eluent pushes the tailing part of a peak forward.  increases the peak height (the peak looks "sharper")  may include sudden "step" increases in the percentage of the organic component, or different slopes at different times. SSJCP, Department of Pharmaceutical Analysis 124
  • 125.  In isocratic elution, the selectivity does not change if the column dimensions (length and inner diameter) change  In gradient elution, the elution order may change as the dimensions or flow rate change  The driving force in RPC originates in the high order of the water structure.  The role of the organic component of the mobile phase is to reduce this high order and thus reduce the retarding strength of the aqueous component. SSJCP, Department of Pharmaceutical Analysis 125
  • 126. ISOCRATIC SYSTEM  Same mobile phase concentration throughout the separation  Use 1 pump and pre-mix solvents  Use 1 pump and a valve for 4 different solvents  Use 2 pumps and vary the amount coming from each pump SSJCP, Department of Pharmaceutical Analysis 126
  • 127. ISOCRATIC SEPARATION  1 pump and premixing  4.6 mm ID Column, 1 mL/min, Changing MeOH % vs Water SSJCP, Department of Pharmaceutical Analysis 127
  • 128.  1 pump with valve and premixing To Column To Column A = 80% Methanol, 20% Water B = 70% Methanol, 30% Water ABCD C = 60% Methanol, 40% Water D = 50% Methanol, 50% Water SSJCP, Department of Pharmaceutical Analysis 128
  • 129.  1 pump with mixer – let the pump do the work! To Column To Column Method 1: A.CONC = 20%, B.CONC = 80% Method 2: A.CONC = 30%, B.CONC = 70% Method 3: A.CONC = 40%, B.CONC = 60% ABCD Method 4: A.CONC = 50%, B.CONC = 50% SSJCP, Department of Pharmaceutical Analysis 129
  • 130. LOW PRESSURE GRADIENT 1 Pump, solvents are mixed before the pump Requires degassing To Column To Column ABCD SSJCP, Department of Pharmaceutical Analysis 130
  • 131. HIGH PRESSURE GRADIENT Binary Gradient 2 Pumps and Mixer Ternary Gradient 3 Pumps and Mixer ………. ………. ………. ………. ………. ………. ………. ………. ………. SSJCP, Department of Pharmaceutical Analysis 131
  • 132. HIGH v/s LOW PRESSURE GRADIENT  High Pressure Gradient ► Multiple pumps are used with a mixer after the pumps  Low Pressure Gradient ► Solvents are mixed before the pump SSJCP, Department of Pharmaceutical Analysis 132
  • 133. Gradient v/s Isocratic Conditions: Summarized  Isocratic ► mobile phase solvent composition remains constant with time ► Best for simple separations ► Often used in quality control applications that support and are in close proximity to a manufacturing process  Gradient ► mobile phase solvent (“B”) composition increases with time ► Best for the analysis of complex samples ► Often used in method development for unknown mixtures ► Linear gradients are most popular (for example, the “gradient” shown at right) SSJCP, Department of Pharmaceutical Analysis 133
  • 134. PRINCIPLE OF SEPARATION  The principle of separation is Adsorption.  Separation of components takes place because of the difference in affinity of compounds towards stationary phase. SSJCP, Department of Pharmaceutical Analysis 134
  • 135. The principle of separation in normal phase mode and reverse phase mode is adsorption.  The component which has more affinity towards the adsorbent, travels slower.  The component which has less affinity towards the stationary phase travels faster.  Since no two components have the same affinity towards the stationary phase, the components are separated. 1 Stronger interaction 2 Weaker interaction SSJCP, Department of Pharmaceutical Analysis 135
  • 136. PRESENT CHALLENGES  Analysis of matrices like pharmaceutical dosage forms and biological samples will always be challenging, due to their great diversity, intricacy and complexity.  Analyzing complex samples like biological products and biological fluids is a significant challenge even with today’s advanced and sophisticated instrumentation.  Quality assurance & quality control of pharmaceuticals and formulations play a vital role in ensuring the availability of safe & effective drug products to the population.  Quantitative estimation of the chemical entity of a drug substance is pivotal to its quality assurance and control. SSJCP, Department of Pharmaceutical Analysis 136
  • 137.  The problem may be a simple one when one is dealing with a pure and single substance.  But, during the process of formulation, the original drug substance of high purity is often diluted and mixed with other additives.  This may lead to interferences of the additives in the method of estimation.  The overall aim of our research is to develop new methods for quantitative determination of novel drugs in pharmaceutical dosage forms.  The emphasis is to find new principles for separations using liquid chromatography (HPLC) and to understand the mechanisms behind. SSJCP, Department of Pharmaceutical Analysis 137
  • 138. INSTRUMENTATION SSJCP, Department of Pharmaceutical Analysis 138
  • 139. SCHEMATIC REPRESENTATION OF AN HPLC UNIT 1.Solvent reservoirs 2. Solvent degasser 3. Gradient valve 4. Mixing vessel for delivery of the mobile phase 5. Highpressure pump 6.Switching valve in "inject position” & Switching valve in "load position” 7. Sample injection loop 8.Pre-column(guard column) 9. Analytical column 10. Detector (i.e. IR, UV) 11. Data acquisition 12. Waste or fraction collector SSJCP, Department of Pharmaceutical Analysis 139
  • 140. BASIC FLOW CHART OF A HPLC SYSTEM SETUP SSJCP, Department of Pharmaceutical Analysis 140
  • 141. HPLC System Components  Pumps ► Micro to Analytical to Preparative Flow Rates ► Isocratic and Gradient Configurations  Degasser ► How it Affects Pumping and Sample Injection  Valves ► Solvent Selection and Flow Selection SSJCP, Department of Pharmaceutical Analysis 141
  • 142.  Sample Injection ► Manual Injector or Autosampler  Oven ► How Temperature Affects Separation ► Valves for Column Switching  Detectors ► UV-VIS ► Diode Array ► Fluorescence ► Light Scattering ► Refractive Index ► Conductivity ► Mass Spectrometer  Recorders and Integrators SSJCP, Department of Pharmaceutical Analysis 142
  • 143.  Fraction Collector ► Isolate Specific Sample Components ► Purify Compounds for Multi-Step Synthesis  Column ► Types of Packing Material ► Factors Affecting Separation ► Particle Size and Column Length ► Flow Rate and Temperature SSJCP, Department of Pharmaceutical Analysis 143
  • 144. A SOLVENT DELIVERY SYSTEM  A mobile phase is pumped under pressure from one or several reservoir and flows through the column at a constant rate.  For NP separation eluting power increases with increasing polarity of the solvent but for reversed phase separation, eluting power decreases with increasing polarity.  A degasser is needed to remove dissolved air and other gases from the solvent. SSJCP, Department of Pharmaceutical Analysis 144
  • 145. HPLC DEGASSING  Degassing removes dissolved air that interferes with check valve operation  Refluxing ► not practicable  Ultrasonic degassing ► ineffective & applicable for ACN/ Water  Helium sparge ► Gas line from the tank directly in the solvent bottle  Vacuum degassing ► Sonicate before connecting to the system ► Online with a degassing unit SSJCP, Department of Pharmaceutical Analysis 145
  • 146. Various solvent delivery systems SSJCP, Department of Pharmaceutical Analysis 146
  • 147. PUMP MODULES Types:  Isocratic pump ► delivers constant mobile phase composition; ► solvent must be pre-mixed; ► lowest cost pump  Gradient pump ► delivers variable mobile phase composition; ► can be used to mix and deliver an isocratic mobile phase or a gradient mobile phase  Binary gradient pump ► delivers two solvents  Quaternary gradient pump ► four solvents SSJCP, Department of Pharmaceutical Analysis 147
  • 148.  The pump is one of the most important component of HPLC, since its performance directly affects retention time, reproducibility and detector sensitivity.  Three main types of pumps are used in HPLC. ►Displacement pump ► Reciprocating pump ► Pneumatic (or) constant pressure pump SSJCP, Department of Pharmaceutical Analysis 148
  • 149.  DISPLACEMENT PUMP: It produce a flow that tends to independent of viscosity and back pressure and also output is pulse free but possesses limited capacity (250ml).  RECIPROCATING PUMP: It has small internal volume (35400µl), their high output pressure(up to 10,000psi) and their constant flow rates. But it produces a pulsed flow.  PNEUMATIC (OR) CONSTANT PRESSURE PUMP: ► They are pulse free . ► Suffer from limited capacity as well as a dependence of flow rate on solvent viscosity and column back pressure. ► They are limited to pressure less than 2000 psi. SSJCP, Department of Pharmaceutical Analysis 149
  • 150. HPLC PUMPS – TWO BASIC TYPES  Tandem piston ► Two pistons with different volumes (48 and 24 µL) ► During each stroke, 24 µL of liquid is delivered ► Best for higher analytical flow rates, up to 10 mL/min ► Some pulsation is observed, and pulse dampeners are available ► Not recommended for pulse-sensitive detectors like RID and CDD SSJCP, Department of Pharmaceutical Analysis 150
  • 151. TANDEM PISTON PUMP Secondary Piston ↓ ← Primary Piston SSJCP, Department of Pharmaceutical Analysis 151
  • 152. DUAL PISTON  Two pistons with equal volume (10 µL each)  During each stroke, 10 µL is delivered  Best for low flow rates (< 1 mL/min)  Little to NO pulsation  So it’s ideal for pulse sensitive detectors like RID and CDD SSJCP, Department of Pharmaceutical Analysis 152
  • 153. DUAL PISTON SSJCP, Department of Pharmaceutical Analysis 153
  • 154. OTHER PUMP COMPONENTS  Check Valves ► Control liquid movement in and out of the pump head SSJCP, Department of Pharmaceutical Analysis 154
  • 155.  Piston/plunger seal ► Prevents solvent leakage out of pump head  Inline filter ► Removes solvent particulates SSJCP, Department of Pharmaceutical Analysis 155
  • 156. VALVES USED WITH PUMPS  Solvent Selection – 2 Solvents Per Pump ► Use for solvent switching SSJCP, Department of Pharmaceutical Analysis 156
  • 157.  Solvent Selection – 2 Solvents Per Pump ► Use for pump loading of large sample volumes SSJCP, Department of Pharmaceutical Analysis 157
  • 158.  Solvent Selection – 4 Solvents Per Pump ► Use for low pressure gradient formation SSJCP, Department of Pharmaceutical Analysis 158
  • 159.  Solvent Selection – 4 Solvents Per Pump ► Use for different gradients in method development SSJCP, Department of Pharmaceutical Analysis 159
  • 160. SAMPLE INJECTION SYSTEM  There are three important ways of introducing the sample in to the injection port. ► Loop injection : in which a fixed amount of volume is introduced by making use of fixed volume loop injector. ► Valve injection: in which, a variable volume is introduced by making use of an injection valve. ► On column injection: in which, a variable volume is introduced by means of a syringe through a septum. SSJCP, Department of Pharmaceutical Analysis 160
  • 161. SSJCP, Department of Pharmaceutical Analysis 161
  • 162. SAMPLE INJECTION – MANUAL  Manual Injector with Syringe ► Fixed loop of varying sizes (1 to 20 mL or more) ► Fill with syringes of varying sizes ► Can include a switch to start a data system SSJCP, Department of Pharmaceutical Analysis 162
  • 163. SAMPLE INJECTION – AUTOMATIC  Fixed-Loop Auto sampler ► Loop is installed on the valve and can be changed for different injection volumes ► External syringe draws sample and fills loop  Advantages: ► low cost ► rugged ► few moving parts  Disadvantages: ► Poor performance for low volume injections higher carryover ► always some sample loss SSJCP, Department of Pharmaceutical Analysis 163
  • 164. Sample Injection… how is a sample actually put into an LC system  Manual Injector: 1. User manually loads sample into the injector using a syringe and then turns the handle to inject sample into the flowing mobile phase which transports the sample into the beginning (head) of the column, which is at high pressure  Autosampler: 1. User loads vials filled with sample solution into the autosampler tray (100 samples) and the autosampler automatically : 2. measures the appropriate sample volume, 3. injects the sample, 4. then flushes the injector to be ready for the next sample, etc., until all sample vials are processed for unattended automatic operation SSJCP, Department of Pharmaceutical Analysis 164
  • 165. SAMPLE INJECTION – FIXED LOOP  External syringe draws sample, then fills the fixed-volume loop attached to the valve. SSJCP, Department of Pharmaceutical Analysis 165
  • 166.  Needle-in-the-flow path auto sampler ► Sample loop and needle are a single piece of tubing ► Loop and needle are cleaned during the run ► Metering pump draws sample very precisely  Advantages: ► no sample loss, ► low carryover  Disadvantages: ► higher cost ► more delay volume for gradient SSJCP, Department of Pharmaceutical Analysis 166
  • 167. SAMPLE INJECTION TO FLOW PATH Sample Loading SSJCP, Department of Pharmaceutical Analysis 167
  • 168. RINSING AFTER INJECTION Rinse liquid flows through ports 5 and 6 of the high pressure valve. Sample aspiration uses port 5. If air is present around port 5, injection reproducibility will be low. Rinse liquid degassed! SSJCP, Department of Pharmaceutical Analysis MUST be 168
  • 169. %A {H2O} %B %C {MeOH} Flow Rate Pressure (mL/min) (atmos.) to column load Ready inject Rheodyne Injector Varian 9010 Solvent Delivery System to injector through pulse dampener Ternary Pump A Column through pump C B SSJCP, Department of Pharmaceutical Analysis from solvent reservoir to det ect or 169
  • 170. CHROMATOGRAPHIC COLUMN  The column is usually made up of heavy glass or stainless steel tubule to withstand high pressure  The columns are usually 10-30cm long and 4-10mm inside diameter containing stationary phase at particle diameter of 25µm or less  Column with internal diameter of 5mm give good results because of compromise between efficiency, sample capacity, and the amount of packaging and solvent required SSJCP, Department of Pharmaceutical Analysis 170
  • 171.  Within the Column is where separation occurs  Key Point – Proper choice of column is critical for success in HPLC  Types of columns in HPLC: ►Analytical [internal diameter (i.d.) 1.0 - 4.6-mm; lengths 15 – 250 mm] ► Preparative (i.d. > 4.6 mm; lengths 50 – 250 mm) ► Capillary (i.d. 0.1 - 1.0 mm; various lengths) ► Nano (i.d. < 0.1 mm, or sometimes stated as < 100 µm)  Materials of construction for the tubing ► Stainless steel (the most popular; gives high pressure capabilities) ► Glass (mostly for biomolecules) ► PEEK polymer (biocompatible and chemically inert to most solvents) SSJCP, Department of Pharmaceutical Analysis 171
  • 172. HPLC Columns Packing Materials  Columns are packed with small diameter porous particles.  The most popular sizes are: 5-μ m, 3.5- μ m and 1.8-μ m  Columns are packed using high-pressure to ensure that they are stable during use. Most users purchase pre-packed columns to use in their liquid chromatographs  These porous particles in the column usually have a chemically bonded phase on their surface which interacts with the sample components to separate them from one another for example, C18 is a popular bonded phase  The process of retention of the sample components (often called analytes) is determined by the choice of column packing and the selection of the mobile phase to push the analytes through the packed column. SSJCP, Department of Pharmaceutical Analysis 172
  • 173. HPLC COLUMN OVENS  Block heater with solvent preheater ► Column is housed between 2 metal plates ► Mobile phase is plumbed into the block for preheating  Forced air ► Column is in a large chamber with air circulation ► Better temperature equilibration ► Room for column switching valves SSJCP, Department of Pharmaceutical Analysis 173
  • 174. Why Use a Column Oven?  Retention times decrease & higher flow rates possible 2.1 mm ID Column, 0.35 mL/min, 50/50 MeOH/Water 50°C 45°C 40°C 35°C 30°C 25°C 20°C SSJCP, Department of Pharmaceutical Analysis 174
  • 175. DETECTORS  The function of detector in HPLC is to monitor the mobile phase as it merges from the column.  Detectors are usually of two types: ► Bulk property detectors: It compares overall changes in a physical property of the mobile phase with and without an eluting solute e.g. refractive index ,dielectric constant or density. ► Solute property detectors: It responds to a physical property of the solute which is not exbited by the pure mobile phase.e.g.UV absorbance,fluoroscence or diffusion current. SSJCP, Department of Pharmaceutical Analysis 171 175
  • 176. TYPES OF DETECTORS There are mainly 4 types of detectors are used in HPLC:  Photometric detectors. ► Single wavelength detectors. ► Multi wavelength detectors. ► Variable wavelength detectors. ► Programmable detectors. ► Diode array detectors .  Fluorescence detectors.  Refractive index detectors.  Electrochemical detectors.  Evaporative light scattering detectors  IR detectors  UV detectors SSJCP, Department of Pharmaceutical Analysis 176
  • 177. PHOTOMETRIC DETECTORS  These normally operate in the ultra violet region of the spectrum .  Most extensively used in pharmaceutical analysis. SSJCP, Department of Pharmaceutical Analysis 177
  • 178. SINGLE WAVELENGTH DETECTORS  Equipped with a low pressure mercury discharge lamp.  The absorbance is measured at the wavelength of mercury at 254 nm. SSJCP, Department of Pharmaceutical Analysis 178
  • 179. MULTI WAVELENGTH DETECTORS  Employ mercury and other discharge sources.  When used in combination with interference filters allow a no of monochromatic wavelengths to be selected e.g. 206, 226, 280 , 313, 340 or 365 nm. SSJCP, Department of Pharmaceutical Analysis 179
  • 180. Multi-wavelength UV-Vis Absorption Detector Deuterium Lamp SSJCP, Department of Pharmaceutical Analysis Photodiode Array 180
  • 181. VARIABLE WAVELENGTH DETECTORS  Use a deuterium light source.  A grating monochromator to allow selection of any wavelength in deuterium continuum (190-360 nm). SSJCP, Department of Pharmaceutical Analysis 177 181
  • 182. UV-VISIBLE DETECTOR  UV-Visible ► Wavelength range 190-700 nm ► D2 and W lamps  Most common HPLC detector for a variety of samples ► Proteins and peptides ► Organic molecules ► Pharmaceuticals  Monitor two wavelengths at one time SSJCP, Department of Pharmaceutical Analysis 182
  • 183. UV-Visible Detector SSJCP, Department of Pharmaceutical Analysis 183
  • 184. Variable wavelength detector SSJCP, Department of Pharmaceutical Analysis 184
  • 185. Variable UV/Vis Detector ABS AUFS λ RunTime EndTime 0.001 2.000 238 0.00 min 10.0 min Ready SSJCP, Department of Pharmaceutical Analysis 185
  • 186. PROGRAMMABLE DETECTORS  Allow the automatic change of wavelength between and during the chromatographic analysis. SSJCP, Department of Pharmaceutical Analysis 186
  • 187. DIODE ARRAY DETECTORS  They are microprocessor – controlled photodiode array spectrophotometers in which light from an UV source passes through the flow cell into a polychromator which disperses the beam so that the full spectrum falls on the array of diodes. SSJCP, Department of Pharmaceutical Analysis 183 187
  • 188. DIODE ARRAY DETECTOR  Wavelength range 190-900 nm  D2 and W lamps  Spectral information about sample  Create compound libraries to identify unknowns  Monitor an entire wavelength range at one time – up to 790 wavelengths vs. only 2 with a UV detector SSJCP, Department of Pharmaceutical Analysis 188
  • 189. DIODE ARRAY DETECTOR SSJCP, Department of Pharmaceutical Analysis 189
  • 190. FLUORESCENCE DETECTOR  These are essentially filter fluorimeter or spectro -fluorimeters equipped with grating monochromators, and micro flow cell.  Their sensitivity depends on the fluorescence properties of the components in the elute. SSJCP, Department of Pharmaceutical Analysis 190
  • 191.  Fluorescence detector ► Xenon lamp for light source ► Excitation wavelength range: 200-650 nm ► Emission wavelength range: up to 900 nm depending on photomultiplier installed  Used primarily for amino acid analysis ► Derivatize samples before (pre-column) or after separation( post-column) SSJCP, Department of Pharmaceutical Analysis 191
  • 192. Fluorescence Detector SSJCP, Department of Pharmaceutical Analysis 192
  • 193. REFRACTIVE INDEX DETECTORS  Which respond to the change in the bulk property of the refractive index of the solution of the component in the mobile solvent system.  The sensitivity of the refractive index detector is much less than that of specific solute property detectors, they are useful for the detection of substances(e.g ,carbohydrates & alcohols) which do not exhibit other properties that can be used as the basis for specific detection. SSJCP, Department of Pharmaceutical Analysis 193
  • 194. Refractive Index Detector  For samples with little or no UV Absorption  Alcohols, sugars, saccharides, fatty acids, polymers  Best results when RI of samples is very different from RI of mobile phase  Flow cell is temperature controlled with a double insulated heating block  Requires isocratic separations  Requires low pulsation pumps SSJCP, Department of Pharmaceutical Analysis 194
  • 195. RI BALANCE  Fill sample and reference cell with mobile phase SSJCP, Department of Pharmaceutical Analysis 195
  • 196. RI ANALYZE  Mobile phase flows through sample side only  As the refractive index changes, the image on the photodiode is deflected or “unbalanced”, and the difference in current to the photodiode is measured. SSJCP, Department of Pharmaceutical Analysis 196
  • 197. Refractive Index Detector SSJCP, Department of Pharmaceutical Analysis 197
  • 198. ELECTROCHEMICAL DETECTORS  These are based on standard electrochemical principles involving amperometry,voltametryand polarography.  These detectors are very sensitive for substances that are electroactive ,i.e. those that undergo oxidation or reduction .  They have found particular application in the assay of low levels of endogenous catecholamines in biological tissues,pesticides,tryptophan derivatives and many drugs. SSJCP, Department of Pharmaceutical Analysis 198
  • 199. Electrochemical Detector SSJCP, Department of Pharmaceutical Analysis 199
  • 200. EVAPORATIVE LIGHT SCATTERING (ELSD)  Also for low or no UV absorbing compounds  Sometimes called a “Universal” detector  Requires NO equilibration (unlike RID)  Can be used with gradients and volatile buffers (unlike RID)  Semi-volatile compounds can be detected at low temperatures SSJCP, Department of Pharmaceutical Analysis 200
  • 201. ELSD OPERATION Column Effluent Nebulizer Nebulizer Gas (Air or Nitrogen) Nebulization Chamber Analyte Drift Tube (Heated Zone Evaporation Area) PMT Light Source Amplifier Light Scattering Cell SSJCP, Department of Pharmaceutical Analysis Signal Output 201
  • 202. ELSD v/s OTHER DETECTORS  ELSD has higher sensitivity than UV and RID  ELSD can be used with gradients, unlike RID SSJCP, Department of Pharmaceutical Analysis 202
  • 203. CONDUCTIVITY DETECTOR  Flow cell contains 2 electrodes  Measure ion amounts in sample  REQUIRES low pulsation pumps  Flow cell must be placed in a column oven SSJCP, Department of Pharmaceutical Analysis 203
  • 204.  Use in Environmental and water testing ► Fl-, Cl- NO3-, PO43-, SO42► Li+, Na+, K+, Mg2+, Cu2+, M-CN complexes  Determine organic acids in fruit juice ► Oxalic, Maleic, Malic, Succinic, Citric  Analyze surfactants ► Sulfonates, long/short chain ammonium SSJCP, Department of Pharmaceutical Analysis 204
  • 205. Mass Spectrometer Detector  Separate sample components as ions according to their mass to charge (m/z) ratio  Three stages to detection  Vaporization: liquid from HPLC column converted to an aerosol  Ionization: neutral molecules converted to charged species (either positive or negative)  Mass Analysis: filter ions by m/z ratio SSJCP, Department of Pharmaceutical Analysis 205
  • 206. TWO IONIZIZATION TYPES  APCI: Atmospheric Pressure Chemical Ionization ► For molecules up to 1000 Da ► Singly charges ions ► Best for analysis of non-polar molecules  ESI: Electrospray Ionization ► Can be used for large biopolymers ► Forms multiply charged ions ► Best for the analysis of polar molecules, especially pharmaceutical products and proteins SSJCP, Department of Pharmaceutical Analysis 206
  • 207. MS DETECTOR Heated capillary Q-array Orthogonal source geometry Octapole Electron Multiplier Detector Quadrupole mass analyser SSJCP, Department of Pharmaceutical Analysis 207
  • 208. FRACTION COLLECTOR  Purify raw materials or compounds from synthesis  Collect by slope, level, time, volume  Isolate single peaks per tube, or divide peaks into small “slices” for extra purity SSJCP, Department of Pharmaceutical Analysis 208
  • 209. Temperature Control in HPLC: Why is it needed?  Reproducibility ► Retention in HPLC is temperature-dependent ► If temperature varies, then it is difficult to assign “peaks” to specific compounds in the chromatogram and the peak areas/heights may vary  Solubility ► Certain chemical compounds may have low solubility in the HPLC mobile phase ► If they are injected into the flow stream they may precipitate or other difficulties may arise  Stability ► Certain chemical compounds, especially biological compounds such as enzymes or proteins, may not be stable at room temperature or higher ► The temperature needs to be much lower down to 4°C SSJCP, Department of Pharmaceutical Analysis 209
  • 210. How is Temperature Control Achieved?  Three (3) ways the temperature of a column could be controlled, use: ► Oven ► Heater Block ► Water bath SSJCP, Department of Pharmaceutical Analysis 210
  • 211. What is HPLC used for?  Separation and analysis of non-volatile or thermally-unstable compounds  HPLC is optimum for the separation of chemical and biological compounds that are non-volatile  NOTE: If a compound is volatile (i.e. a gas, fragrance, hydrocarbon in gasoline, etc.), gas chromatography is a better separation technique. SSJCP, Department of Pharmaceutical Analysis 211
  • 212.  Typical non-volatile compounds are: ► Pharmaceuticals like aspirin, ibuprofen, or acetaminophen (Tylenol) ► Salts like sodium chloride and potassium phosphate ► Proteins like egg white or blood protein ► Organic chemicals like polymers (e.g. polystyrene, polyethylene) ► Heavy hydrocarbons like asphalt or motor oil ► Many natural products such as ginseng, herbal medicines, plant extracts ► Thermally unstable compounds such as trinitrotoluene (TNT), enzymes etc…. SSJCP, Department of Pharmaceutical Analysis 212
  • 213. FOR QUALITATIVE ANALYSIS  The identification(ID) of individual compounds in the sample; ► the most common parameter for compound ID is its retention time (the time it takes for that specific compound to elute from the column after injection); ► depending on the detector used, compound ID is also based on the chemical structure, molecular weight or some other molecular parameter. SSJCP, Department of Pharmaceutical Analysis 213
  • 214. FOR QUANTITATIVE ANALYSIS  The measurement of the amount of a compound in a sample (concentration); meaning, how much is there?  There are two main ways to interpret a chromatogram (i.e. perform quantification): ► determination of the peak height of a chromatographic peak as measured from the baseline; ► determination of the peak area (see figure below);  In order to make a quantitative assessment of the compound, a sample with a known amount of the compound of interest is injected and its peak height or peak area is measured.  In many cases, there is a linear relationship between the height or area and the amount of sample. SSJCP, Department of Pharmaceutical Analysis 214
  • 215. Preparation of Pure Compound(s)  By collecting the chromatographic peaks at the exit of the detector  and concentrating the compound (analyte) by removing/evaporating the solvent  a pure substance can be prepared for later use (e.g. organic synthesis, clinical studies, toxicology studies, etc….).  This methodology is called preparative chromatography. SSJCP, Department of Pharmaceutical Analysis 215
  • 216. Trace analysis  A trace compound is a compound that is of interest to the analyst but it’s concentration is very low, usually less than 1% by weight, often parts per million (ppm) or lower;  the determination of trace compounds is very important in pharmaceutical, biological, toxicology, and environmental studies since even a trace substance can be harmful or poisonous;  in a chromatogram trace substances can be difficult to separate or detect;  high resolution separations and very sensitive detectors are required SSJCP, Department of Pharmaceutical Analysis 216
  • 217. SSJCP, Department of Pharmaceutical Analysis 217
  • 218. SEPARATION TECHNIQUES IN HPLC METHOD DEVELOPMENT GOAL COMMENT Resolution Precise and rugged quantitative analysis requires that Rs be greater than 1.5 Separation time 3-10 min is desirable for routine procedures Quantitation ≤2% for assays; ≤ 5% for less-demanding analyses; ≤ 15% for trace analyses Peak Height Narrow peaks are signal/noise ratios Solvent composition Minimum mobile-phase use per run is desirable desirable SSJCP, Department of Pharmaceutical Analysis for large 218
  • 219. THE VALIDATION PROCESS ► It consists of four distinct steps: Software validation Hardware (instrumentation) validation/qualification Method validation System suitability SSJCP, Department of Pharmaceutical Analysis 219
  • 220. HPLC SYSTEM QUALIFICATION SSJCP, Department of Pharmaceutical Analysis 220
  • 221. GOALS FOR AN IMPROVED ANALYTICAL METHOD DEVELOPMENT ► Qualitative identification - structural information, retention time, color change, pH etc ► Quantitative determination - accurate, precise and reproducible in any laboratory settings ► Ease of use, viability to be automated, high sample throughput, and rapid sample turnaround time. ► Decreased cost per analysis - using simple quality assurance and quality control procedures SSJCP, Department of Pharmaceutical Analysis 221
  • 222. ► Sample preparation minimizing - time, effort, materials, and volume of sample consumed ► Direct output of qualitative or quantitative data evaluations, interpretation, printing out and transmission OPTIMIZATION & ANALYTICAL FIGURES OF MERIT ► initial sets of conditions - resolution, peak shape, plate counts, asymmetry, capacity, elution time, detection limits ► quantifying the specific analyte of interest, accuracy and precision of Quantitation and specificity must be defined. SSJCP, Department of Pharmaceutical Analysis 222
  • 223. ► Chromatographic resolution adequate ► Limits of detections are lower ► Calibration plots are linear ► Sample throughout is increased ► Sample preparation before analysis is minimized ► Interference is minimized and identified ► Data acquisition - translated, interpreted, printed & stored ► Reproducibility of analytical figures of merit & Cost per analysis is minimized SSJCP, Department of Pharmaceutical Analysis 223
  • 224. METHOD VALIDATION APPROACHES ► Samples of the given analyte ► Concentration in the matrix ► High degree of accuracy and precision ► Zero, Single and Double –Blind spiking methods ► Inter laboratory collaborative studies ► Comparison with a currently accepted compendium method SSJCP, Department of Pharmaceutical Analysis 224
  • 225. STEP-BY-STEP HPLC METHOD DEVELOPMENT, OPTIMIZATION AND VALIDATION: AN OUTLINE ► Analyte Standard Characterization ► Method Requirements ► Literature Search and Prior Methodology ► Choosing a Method ► Instrument Setup and Initial Studies ► Optimization ► Demonstration of Analytical Figures of Merit with Standards SSJCP, Department of Pharmaceutical Analysis 225
  • 226. ► Evaluation of Method Development with Actual Samples and Derivation of Figures of Merit ► Validation of Figures of Merit ► Determination of Percent Recovery of Actual Sample and Demonstration of Quantitative Sample Analysis ► Method Validation ► Preparation of Written Protocols and Procedures ► Transfer of Method Technology to Outside Laboratories and Interlaboratory Collaborative Studies SSJCP, Department of Pharmaceutical Analysis 226
  • 227. ► Comparison of Interlaboratory Collaborative Studies ► Preparation of Summary Report on Overall Method Validation Results ► Summary Report of Final Method and Validation Procedures and Results and also Preparation of Journal Article for Submission THE OUTLINE PROTOCOL OF HPLC METHOD SSJCP, Department of Pharmaceutical Analysis 227
  • 228. STEPS FOR HPLC METHOD DEVELOPMENT Information on sample, define separation goals Validate method for release to routine laboratory Need for special procedure sample pretreatment, etc Quantitative calibration Choose detector and detector settings Choose LC method; preliminary run; estimate the best separation conditions Check for problems or requirement for special procedure Optimize separation conditions SSJCP, Department of Pharmaceutical Analysis
  • 229. PARAMETERS USED IN METHOD VALIDATION SSJCP, Department of Pharmaceutical Analysis 229
  • 230. SPECIFICITY ► It is the ability to measure accurately and specifically the analyte of interest in the presence of other components that may be expected to be present in the sample matrix ► Specificity is also measured and documented in a separation by the resolution, plate count (efficiency) and tailing factor ► Blank solution to show no interference with excipients or degradation products or impurities ► Placebo to demonstrate the lack of interference from excipients ► Spiked samples to show that all known related substances are resolved from each other SSJCP, Department of Pharmaceutical Analysis 230
  • 231. LINEARITY AND RANGE ► It is the ability of the method to elicit test results that are directly proportional to analyte concentration within a given range ► Reported as the variance of the slope of the regression line ► ICH guidelines specify a minimum of five concentration levels ► Assay : 80-120% of the theoretical content of active Content Uniformity: 70-130% ► Dissolution: ±20% of limits; e.g if limits cover from 20% to 90% l.c. (controlled release), linearity should cover 0-110% of l.c. SSJCP, Department of Pharmaceutical Analysis 231
  • 232. ► Impurities: reporting level to 120% of shelf life limit ► Assay/Purity by a single method: reporting level of the impurities to 120% of assay limit ► Correlation coefficient (r) = API: ≥ 0.998 & Impurities: ≥ 0.99 ► y-intercept and slope should be indicated together with plot of the data SSJCP, Department of Pharmaceutical Analysis 232
  • 233. ACCURACY ► Measure of exactness of an analytical method or closeness of agreement between the measured value and the value that is accepted either as a conventional, true value or an accepted reference value ► Measured as percentage of analyte recovered by assay, by spiking samples in a blind study ► API (Active Pharmaceutical Ingredient): against an RS (Reference Standard) of known purity, or via an alternate method of known accuracy; analysis in triplicate ► FPP (Finished Pharmaceutical Product): samples/placeboes spiked with API, across the range of 80-120% of the target concentration, 3 concentrations, in triplicate each SSJCP, Department of Pharmaceutical Analysis 233
  • 234. ► Report % recovery (mean result and RSD): 100±2% ► Impurities: API/FPP spiked with known impurities ► Across the range of LOQ-150% of the target concentration (shelf life limit), 3-5 concentrations, in triplicate each. (LOQ, 50%, 100%, 150%) ► % recovery: in general, within 80-120%, depends on the level of limit ► ICH Q2 states: accuracy may be inferred once precision, linearity and specificity SSJCP, Department of Pharmaceutical Analysis 234
  • 235. LOD / LOQ ► LOD: the lowest concentration of an analyte in a sample that can be detected though not necessarily quantitated. ► LOQ: the lowest concentration of an analyte in a sample that can be determined with acceptable precision and accuracy under the stated operational conditions of the method ► signal to noise ratio: LOD = 3:1 , LOQ = 10:1 ● May vary with lamp aging, model/manufacturer of detector, column ► standard deviation of the response and the slope of the calibration curve at levels approximating the LOD /LOQ ● σ = the standard deviation of the response, based on the standard deviation of the blank & the calibration curve & S = Slope SSJCP, Department of Pharmaceutical Analysis
  • 236. ► should be validated by analysis of samples at the limits ► LOD: below the reporting threshold ► LOQ: at or below the specified limit ► Not required for assay/dissolution methods ► Applicant should provide ● the method of determination ● the limits ● chromotograms SSJCP, Department of Pharmaceutical Analysis 236
  • 237. ROBUSTNESS / RUGGEDNESS ► Robustness: capacity of a method to remain unaffected by small deliberate variations in the method parameters ► Ruggedness: degree of reproducibility of the results obtained under a variety of conditions, expressed as % RSD ► Evaluated by varying method parameters such as percent organic solvent, pH, ionic strength or temperature , determining the effect on the results of the method, columns, laboratories, analysts, instruments, reagents and experimental periods. SSJCP, Department of Pharmaceutical Analysis 237
  • 238. SYSTEM SUITABILITY TESTING (SST) ► used to verify resolution, column efficiency, and repeatability of the analysis system to ensure its adequacy for performing the intended application on a daily basis. ►Parameters: ● Number of theoretical plates (efficiency) ● Capacity factor ● Separation (relative retention) ● Resolution ● Tailing factor ● Relative Standard Deviation (Precision) SSJCP, Department of Pharmaceutical Analysis 238
  • 239. Center for Drug Evaluation and Research (CDER) Limits for SST SSJCP, Department of Pharmaceutical Analysis 239
  • 240. CHARACTERISTICS TO BE VALIDATED IN HPLC CHARACTERISTICS ACCEPTANCE CRITERIA Accuracy/trueness Recovery 98-102% with 80, 100 & 120% spiked sample Repeatability RSD < 2% Intermediate precision RSD < 2% Specificity/selectivity No interference Detection limit S/N > 2 or 3 Quantitation limit S/N > 10 Linearity Correlation coefficient r > 0.999 Range 80 – 120% Stability of sample solution > 24 hours or > 12 hours SSJCP, Department of Pharmaceutical Analysis 240
  • 241. TYPICAL HPLC INSTRUMENT VERIFICATION REPORT TEST ITEM USER LIMIT ACTUAL LIMIT DAD noise < 5 X 10-5 AU 1 X 10-5 AU Baseline drift < 2x 10-3 AU/hour 1.5 X 10-4 AU/hour DAD WL calibration ± 1 nm ± 1 nm DAD linearity 1.5 AU 2.2 AU Pump performance < 0.3% RSD RT 0.15% RSD RT Temperature stability ± 0.15° C (column heater) ± 0.15° C Precision of peak area 0.09% RSD 0.5% RSD SSJCP, Department of Pharmaceutical Analysis 241
  • 242. METHOD VALIDATION PROTOCOL 1. On day 1, a linearity test over 5 levels for both the drug substance (bulk) and dosage form is performed 2. Comparison of the results between the drug substance and dosage form fulfills the accuracy requirement 3. At the end of day 1, 6 repetitions are performed at 100% of the drug substance for repeatability 4. Steps 1 and 2 are repeated over 2 additional days for intermediate precision 5. LOQ is evaluated by analyzing the drug substance over 5 levels, plus 6 repetitions for precision 6. Baseline noise is evaluated over 6 repetitions of blank injections for the determination of LOD. SSJCP, Department of Pharmaceutical Analysis 242
  • 243. TROUBLE SHOOTING (TIPS & FACTS) ASK PULLA For any further clarification or details of the below content(s) feel free to mail me : ravipratappulla@gmail.com SSJCP, Department of Pharmaceutical Analysis 243
  • 244. 1.What is HPLC anyway? 2. How to become friendly with your HPLC equipment? 3. How to get started? 4. Which column do I have to install in the HPLC instrument? 5. How do I prepare a mobile phase? 6. What is the requirement of equilibrating the system before the advent of sample preparation. 7. What do I have to pay attention to before starting a measurement? 8. How do I start working with the HPLC equipment? 9. What's the reason for quitting your HPLC system? SSJCP, Department of Pharmaceutical Analysis 244
  • 245. SIMPLE TESTS & DECISION CRITERIA 10.What does the name of a column tell us? 11. Is this C18 column the right choice for my sample? 12. Why are polar solutes well separated with one C18 column and hardly at all with another? 13. How can I clean the RP Phase quickly? 14. How best do I degas my mobile phase? 15. Methanol or Acetonitrile? Best choice of solvent…..? 16. The pH of the mobile phase too high or too low. What can I do? 17.What is the right ionic strength of the buffer? 18.How to make sense of the dead volume of an isocratic apparatus? 19.Producing a gradient chromatogram – influence of instrumentation? 20. Does the pump work correctly, precisely or accurately? SSJCP, Department of Pharmaceutical Analysis 245
  • 246. 21. How to test an HPLC instrument and its modules? 22. Injections of solutes as an aqueous solutions? 23. What is the largest tolerable injection volume? 24 . How critical are the temperature changes? 25. How to choose HPLC equipment and a supplier? 26. Is the current method a robust one? PROBLEMS & THEIR SOLUTIONS 27. Sample preparation – how critical are which mistakes? 28. Flushing of an HPLC equipment? 29. Dirt in the UV detection cell? 30. The lamp is new – what happened to the peak? 31. What are the causes of pressure changes or deviations? SSJCP, Department of Pharmaceutical Analysis 246
  • 247. 32. Is the right or the left pump head defective? 33. Baseline noise and damping? 34. The retention times increase- is it the pump or the M.P ? 35. Which buffer is right for which pH? 36. An interesting alternative for the separation of acids & bases with a buffer….. 37. What can be the reasons for a change in retention times? 38. I use up a lot of RP columns; what should I do? 39. Why does my NP system not work any more? 40. Chemical tailing at the presence of metal ions? 41. How to avoid memory effects? 42. How do the default values on my PC affect the resolution? SSJCP, Department of Pharmaceutical Analysis 247
  • 248. TIPS TO OPTIMIZE THE SEPARATION 43. Which is the right injection techniques to get sharper peaks? 44. My peaks appear too early – how can I move them in an RP system to later retention times? 45. How can I increase the plate number? 46. Limit of detection: How can I see more? 47. How can I speed up a separation? 48. How can I optimize a separation? 49. Dead volume capacity, capacity factor, selectivity – how can I use them in everyday life? 50. Which flow is optimal for me? 51. How can I optimize a gradient elution? 52. Separation of ionic solutes? What works out best –end capped phases, inert phases, phosphate buffer or ion pairing reagents? SSJCP, Department of Pharmaceutical Analysis 248
  • 249. SITUATION/SYMPTOM/CAUSE EQULIBRATION 53. SLOW COLUMN  RP- Ion pairing long chain 54.VARYING / VARIABLE RETENTION TIMES        gradient insufficient column regeneration time ion pairing insufficient equilibration time isocratic insufficient equilibration time irregular column equilibration time Leak change in M.P composition air trapped in pump SSJCP, Department of Pharmaceutical Analysis 249
  • 250.  buffer capacity insufficient  contamination buildup  equilibration time insufficient for gradient run or changes in isocratic M.P  first few injections – active sites  inconsistent online M.P mixing or delivery  selective evaporation of M.P component  varying column temperature  check valve malfunctioning  pump cavitations, phase collapse (de-wetting process)  Column temperature fluctuations  First few injections adsorption on active sites  column overloading  sample solvent incompatible with M.P SSJCP, Department of Pharmaceutical Analysis 250
  • 251.  Column problem  improper M.P  column aging 55. INCREASED RETENTION TIME          decreasing flow rate, changing M.P composition, loss of bonded S.P, active sites on column packing Low M.P flow rate Column temperature low Improper gradient setting Column activity increasing System not equilibrated SSJCP, Department of Pharmaceutical Analysis 251
  • 252.      M.P removing water from LSC column Incorrect M.P Loss of bonded S.P M.P composition changing Active sites on silica packing 56. DECREASED RETENTION TIME        column overloaded with sample increasing flow rates loss of bonded S.P or base silica from column column aging, basic compounds – pH too low High M.P flow rate Column temperature high SSJCP, Department of Pharmaceutical Analysis 252
  • 253.       Improper gradient Incorrect M.P Column activity decreased System not equilibrated Deactivation by strongly retained garbage Too strong sample solvent 57. RETENTION BEYOND TOTAL PERMEATION VOLUMES  SEC – solute interaction with S.P. SSJCP, Department of Pharmaceutical Analysis 253
  • 254. 58. LOSS OF RESOLUTION           M.P contaminated/deteriorated Obstructed guard or analytical column Column overload with sample Degraded column Column not fully equilibrated Loss of S.P from the column Dirty column Loss of column liquid phase Distorted column bed Wrong column or M.P SSJCP, Department of Pharmaceutical Analysis 254
  • 255. SENSITIVITY 59. Lack of sensitivity  auto sampler flow lines blocked  detector attenuation set too high  first few samples injections  sample adsorption in injector sample loop or column  injector sample loop under filled  not enough sample injected  peak signals are outside  detector’s linear range  sample losses during sample preparation  sample losses on column peak too broad SSJCP, Department of Pharmaceutical Analysis 255
  • 256. BASELINE 60. Distribution At Void  air bubbles in M.P  positive-negative differences in RI of injection solvent & M.P 61. BASELINE DRIFT  Column temperature fluctuations  Non homogeneous M.P  Contaminant or air buildup in detector, sample or reference cell  Plugged outlet line after detector  M.P mixing problem or change in flow rate  Slow column equilibration when changing M.P  M.P contaminated or deteriorated or not prepared from high quality chemicals SSJCP, Department of Pharmaceutical Analysis 256
  • 257.  Strongly retained materials in sample can elute as very broad peaks and appear to be a rising baseline  Detector not set at absorbance maximum but at slope of curve  M.P or sample vaporizing  Failing detector source  Detector problem  Solvent immiscibility  Contamination bleed in system  Solvent demixing  Slow change in pump output  Partial plugging of injection port or sample valve or column inlet by particulate matter  Contaminated or bleed column  Contamination in detector cell SSJCP, Department of Pharmaceutical Analysis 257
  • 258.       Change in detector temperature Malfunction of detector source Contamination in solvent reservoir Previous M.P not removed Negative direction Positive direction 62. BASELINE NOISE (REGULAR)        Air in M.P or detector cell or pump Pump pulsations Incomplete M.P mixing Temperature effect Other electronic equipment on same line Leak or partial blockage of loop injector valve or detector lamp problem Dirty flow cell SSJCP, Department of Pharmaceutical Analysis 258
  • 259. 63. BASELINE NOISE (IRREGULAR)  Leak  M.P contaminated or deteriorated or prepared from low quality materials  Detector or recorder electronics  Air trapped in system  Air bubbles in detector  Detector cell contaminated  Weak detector lamp  Column leaking silica or packing material or column packing passing through detector  Continuous detector lamp problem or dirty in the flow cell  gradient or isocratic proportioning - lack of solvent mixing & malfunctioning proportioning valves SSJCP, Department of Pharmaceutical Analysis 259
  • 260.  occasional sharp spikes,  external electric interferences,  periodic pump pulse,  random contamination buildup,  spikes – bubble in detector & column temperature higher than B.P of solvent RECOVERY 64. POOR SAMPLE RECOVERY  absorption or adsorption of proteins  adsorption on column packing  absorption on tubing and other hardware components  chemisorption on column packing  hydrophobic interactions between S.P & biomolecules SSJCP, Department of Pharmaceutical Analysis 260
  • 261.  less than 90% yield for acidic compounds irreversible adsorption on active sites  less than 90% yield for basic compounds irreversible adsorption on active sites LEAKS 65. LEAKY FITTING      A loose fitting Stripped fitting Over tighten fitting Dirty fitting Mismatched part/fitting SSJCP, Department of Pharmaceutical Analysis 261
  • 262. 66. LEAKS AT PUMP       Loose check valve Mixer seal failure Pump seal failure Pressure transducer failure Pulse damper failure Proportioning valve failure 67. INJECTOR LEAKS       Rotor seal failure Blocked loop Loose injection port seal Improper syringe needle diameter Waste line siphoning Waste line blockage SSJCP, Department of Pharmaceutical Analysis 262
  • 263. 68. COLUMN LEAKS  Loose end fittings  Column packing in ferrule  Improper frit thickness 69. DETECTOR     LEAKS Cell gasket failure Cracked cell window Leaky fittings Blocked waste line SSJCP, Department of Pharmaceutical Analysis 263
  • 264. PROBLEMS DETECTED BY SMELL, SIGHT & SOUND 70. SOLVENT SMELL  Leak  Spill 71. HOT SMELL  Overheating 72. ABNORMAL METER READING  Pressure abnormality  Column oven  Detector lamp failing 73. WARNING LAMP  Pressure limits exceeded  Other warning signals SSJCP, Department of Pharmaceutical Analysis 264

Notes de l'éditeur

  1. HPLC